A hematopoietic progenitor is committed toward the granulocytic lineage. Which transcription factor is most characteristically associated with differentiation toward the neutrophil/polymorphonuclear leukocyte pathway?
---
- (A) GATA1
- (B) C/EBPα
- (C) PU.1
- (D) GATA3
💡 Click to Reveal Answer & Nelson Rationale
Option B (C/EBPα)
Granulocytic differentiation from the common myeloid progenitor toward granulocyte-monocyte progenitors and neutrophils is strongly associated with C/EBPα. In the hematopoietic differentiation pathway, G-CSF acts as the lineage-specific growth factor for neutrophil/polymorphonuclear leukocyte production, while C/EBPα is an important transcription factor for granulocytic commitment. This distinction between growth factors and transcription factors is high-yield.
![[8a389329_1786081895763_1786081899.png]]
A hemoglobin present in early human embryonic life is composed of two ζ-globin chains and two ε-globin chains. Which hemoglobin is being described?
---
- (A) Hemoglobin Gower-1
- (B) Hemoglobin Gower-2
- (C) Hemoglobin Portland
- (D) Hemoglobin F
💡 Click to Reveal Answer & Nelson Rationale
Option A (Hemoglobin Gower-1)
Embryonic hemoglobins are produced during early development before the fetal hemoglobin switch. Hemoglobin Gower-1 is composed of ζ₂ε₂ chains. The ζ-globin chain belongs to the α-like globin cluster on chromosome 16, while the ε-globin chain belongs to the β-like globin cluster on chromosome 11. This makes Gower-1 distinct from Gower-2, Portland, and HbF.
![[88736ec5_1786082058908_1786082061.png]]
A preterm infant born at 28 weeks’ gestation is followed after delivery. Serial hemoglobin analysis shows that fetal hemoglobin remains relatively high compared with a term infant of the same postnatal age. Which of the following best explains this finding?
---
- (A) Premature delivery accelerates γ-globin silencing and causes early HbA predominance
- (B) HbF decline follows postconceptional age more closely than postnatal age alone
- (C) HbA2 normally becomes the predominant hemoglobin during the first 6 months
- (D) HbF persists because β-globin genes are absent until late infancy
💡 Click to Reveal Answer & Nelson Rationale
Option B (HbF decline follows postconceptional age more closely than postnatal age alone)
The figure shows that HbF declines postnatally, but in premature infants the fall in HbF is better interpreted in relation to postconceptional age rather than only chronological postnatal age. Therefore, a preterm infant may continue to have a relatively higher proportion of HbF compared with a term infant of the same postnatal age. This reflects ongoing developmental hemoglobin switching, with gradual decline in γ-globin expression and increasing β-globin expression.
![[b3159484_1786082200958_1786082203.png]]
A researcher studying developmental hemoglobin switching finds that suppression of a transcription factor leads to persistent γ-globin expression and increased HbF production after birth. Which transcription factor is most directly involved in silencing γ-globin expression during the fetal-to-adult hemoglobin switch?
---
- (A) GATA1
- (B) HIF-1α
- (C) BCL11A
- (D) PU.1
💡 Click to Reveal Answer & Nelson Rationale
Option C (BCL11A)
Hemoglobin switching is developmentally regulated and occurs mainly through changes in expression of the β-like globin genes. The first switch occurs around 6 weeks’ gestation from embryonic to fetal globin expression. The second switch leads to adult hemoglobin production, with HbA composed of α₂β₂ chains. BCL11A is a key regulator of this fetal-to-adult hemoglobin switch because it binds near the β-globin gene cluster and silences γ-globin expression, thereby reducing HbF production.
A 5-month-old infant is suspected to have Diamond-Blackfan anemia. CBC shows macrocytic anemia with reticulocytopenia and no other significant cytopenias. Bone marrow cellularity is normal with paucity of erythroid precursors. Which of the following is not a minor supporting criterion for the diagnosis?
---
- (A) Elevated red cell adenosine deaminase
- (B) Congenital anomalies described in classical DBA
- (C) Elevated HbF
- (D) Pathogenic variant described in classical DBA
💡 Click to Reveal Answer & Nelson Rationale
Option D (Pathogenic variant described in classical DBA)
Minor supporting criteria for Diamond-Blackfan anemia include elevated red cell adenosine deaminase, congenital anomalies described in classical DBA, elevated HbF, and absence of evidence for another inherited bone marrow failure syndrome. A pathogenic variant described in classical DBA is not a minor criterion; it is a major supporting criterion. The diagnostic criteria include age younger than 1 year, macrocytic anemia without other significant cytopenias, reticulocytopenia, and normal marrow cellularity with paucity of erythroid precursors.
**Table:** Diagnostic Criteria for Diamond-Blackfan Anemia
![[da19b039_medium_table__2__1786210474.png]]
A 6-year-old child with hereditary spherocytosis develops sudden severe pallor after a febrile illness. CBC shows profound anemia with marked reticulocytopenia. Parvovirus B19 infection is suspected. If bone marrow examination is performed, which finding is most likely?
---
- (A) Ringed sideroblasts with vacuolated erythroid precursors
- (B) Giant pronormoblasts with intranuclear inclusions
- (C) Marked granulocytic hyperplasia with toxic granulation
- (D) Megakaryocytic hypoplasia with increased marrow blasts
💡 Click to Reveal Answer & Nelson Rationale
Option B (Giant pronormoblasts with intranuclear inclusions)
Parvovirus B19 infects erythroid precursors and can produce transient red cell aplasia, especially in children with chronic hemolytic anemia such as hereditary spherocytosis or sickle cell disease. The marrow shows reduced or absent erythroid precursors with characteristic giant pronormoblasts containing intranuclear inclusions. Clinically, this causes an aplastic crisis with sudden worsening anemia and reticulocytopenia.
A 10-year-old child with juvenile idiopathic arthritis develops fatigue and pallor. CBC shows normocytic anemia with a low reticulocyte response. Serum iron and transferrin saturation are low, but ferritin is normal to increased. The anemia is attributed to inflammatory upregulation of hepcidin. Which change most directly causes the low circulating iron?
---
- (A) Ferroportin degradation
- (B) Increased ferroportin expression
- (C) Suppressed HAMP transcription
- (D) Increased macrophage iron export
💡 Click to Reveal Answer & Nelson Rationale
Option A (Ferroportin degradation)
In anemia of chronic disease or inflammation, inflammatory cytokines increase hepatic hepcidin production. Hepcidin binds to ferroportin on enterocytes, macrophages, and hepatocytes, causing its internalization and lysosomal degradation. This decreases intestinal iron absorption and traps iron within macrophages, causing low serum iron despite normal or increased ferritin.
![[bfc8dc1b_1786082913135_1786082915.png]]
A 28-week premature infant is admitted to the NICU and requires frequent blood sampling. At 5 weeks of age, the infant develops symptomatic anemia with Hb 7.6 g/dL. Reticulocyte response is lower than expected for the degree of anemia. Which of the following best explains why erythropoiesis is inadequate in this infant?
---
- (A) The hepatic oxygen sensor is less responsive to hypoxia
- (B) Premature birth rapidly shifts EPO production to the kidney
- (C) Fetal red cells survive longer than adult red cells
- (D) Rapid postnatal growth suppresses marrow erythropoiesis
💡 Click to Reveal Answer & Nelson Rationale
Option A (The hepatic oxygen sensor is less responsive to hypoxia)
In anemia of prematurity, the hemoglobin fall is more rapid and severe than physiologic anemia of infancy, often reaching 7-9 g/dL by 3-6 weeks. Although the infant is anemic, erythropoietin levels are inappropriately low because the developmental switch from hepatic to renal EPO production is not accelerated by premature birth. The preterm infant continues to rely mainly on hepatic EPO synthesis, and the liver oxygen sensor is less sensitive to hypoxia than the renal oxygen sensor, causing a suboptimal erythropoietic response.
An older child with severe malnutrition is placed on a folate-free diet. Because folate stores are limited, megaloblastic anemia can develop relatively quickly. After what duration is megaloblastic anemia expected to occur?
---
- (A) 2-3 weeks
- (B) 2-3 months
- (C) 6-12 months
- (D) 2-3 years
💡 Click to Reveal Answer & Nelson Rationale
Option B (2-3 months)
Folate stores in the body are limited, so folate deficiency can develop quickly in malnourished children or in those with increased demand, such as chronic hemolytic anemia, infection, or malabsorption. On a folate-free diet, megaloblastic anemia develops after about 2-3 months. This is much faster than vitamin B12 deficiency, because vitamin B12 stores are much larger and take longer to deplete.
A 10-year-old child from an endemic region presents with pallor, glossitis, and fatigue. CBC shows macrocytic anemia with hypersegmented neutrophils. Serum vitamin B12 is low, but gastric fluid contains intrinsic factor. Which organism is most likely responsible?
---
- (A) Diphyllobothrium latum
- (B) Taenia saginata
- (C) Taenia solium
- (D) Hymenolepis nana
💡 Click to Reveal Answer & Nelson Rationale
Option A (Diphyllobothrium latum)
This child has megaloblastic anemia due to vitamin B12 deficiency, but intrinsic factor is present, so the defect is not due to intrinsic factor deficiency. Diphyllobothrium latum, the fish tapeworm, can cause vitamin B12 deficiency by competing for or consuming the vitamin in the upper small intestine. This is classically associated with endemic exposure to inadequately cooked freshwater fish.
A 7-year-old child has macrocytic anemia with hypersegmented neutrophils and neurologic symptoms. Serum vitamin B12 is low-normal, and folate level is normal. Which biochemical finding is most specific in supporting vitamin B12 deficiency over folate deficiency?
---
- (A) Methylmalonic acid decreases
- (B) Homocysteine decreases
- (C) Methylmalonic acid increases
- (D) Homocysteine increases
💡 Click to Reveal Answer & Nelson Rationale
Option C (Methylmalonic acid increases)
Vitamin B12 deficiency causes elevation of both methylmalonic acid and homocysteine. However, increased methylmalonic acid is more specific for vitamin B12 deficiency and is especially useful when serum vitamin B12 is low-normal. Homocysteine also increases in folate deficiency, homocystinuria, and renal failure, so it is less specific.
A 7-year-old child has chronic hemolytic anemia, jaundice, splenomegaly, and a family history of splenectomy. Peripheral smear shows spherocytes. A flow cytometry–based screening test is performed using fluorescent eosin-5-maleimide. Which result is expected in this condition?
---
- (A) Increased EMA binding to spectrin-deficient erythrocytes
- (B) Decreased EMA binding to band 3 and related membrane proteins
- (C) Normal EMA binding with increased osmotic resistance
- (D) Increased EMA binding due to reduced surface area-to-volume ratio
💡 Click to Reveal Answer & Nelson Rationale
Option B (Decreased EMA binding to band 3 and related membrane proteins)
This child has features of hereditary spherocytosis. In HS, binding of fluorescently labeled eosin-5-maleimide to band 3 and other red cell membrane proteins is decreased. EMA binding by flow cytometry is a useful screening test because it is easy to perform and has good diagnostic sensitivity and specificity. It is generally more useful than classic osmotic fragility testing, which is not specific and may miss mild cases.
A neonate from Southeast Asia presents with jaundice and anemia, but later becomes asymptomatic. Peripheral smear shows rounded elliptocytes, some with a transverse bar dividing the central pale area. Osmotic fragility is normal, but the EMA test is positive. Which of the following best explains this disorder?
---
- (A) α-spectrin defect causing reduced red cell heat stability
- (B) Band 3 mutation producing a rigid red cell membrane
- (C) Protein 4.2 deficiency causing spherocytic elliptocytosis
- (D) β-spectrin self-association defect causing typical hereditary elliptocytosis
💡 Click to Reveal Answer & Nelson Rationale
Option B (Band 3 mutation producing a rigid red cell membrane)
This clinical picture is most consistent with Southeast Asian ovalocytosis. SAO is found in individuals from New Guinea, Malaysia, Indonesia, and the Philippines. It presents with anemia and jaundice in the neonatal period but usually becomes asymptomatic later. The smear shows rounded elliptocytes, some with a transverse bar across the central pale area. The key molecular defect is a mutant band 3 protein, which stacks anion exchange function and tends to aggregate, producing a rigid red cell membrane. These changes may lead to protection from malaria, particularly cerebral malaria.
<strong>(
A child with hemolytic anemia has peripheral smear showing red cells with regularly distributed surface projections. The finding is suspected to be non-artifactual. Which of the following conditions is classically associated with this morphology?
---
- (A) Chorea-acanthocytosis
- (B) Abetalipoproteinemia
- (C) Pyruvate kinase deficiency
- (D) Hereditary spherocytosis
💡 Click to Reveal Answer & Nelson Rationale
Option C (Pyruvate kinase deficiency)
The smear description suggests echinocytes, also called burr cells. Echinocytes have regularly distributed projections or serrations along the red cell surface. They may be artifacts, but when non-artifactual they may be seen in end-stage renal disease, liver disease, uremia, pyruvate kinase deficiency, long-distance runners, hypomagnesemia, and hypophosphatemia.
A 15-year-old boy is incidentally found to have sickle cell trait during screening. He is asymptomatic. Which of the following is a recognized complication associated with sickle cell trait?
---
- (A) Renal papillary necrosis
- (B) Functional asplenia in early childhood
- (C) Recurrent acute chest syndrome
- (D) Chronic transfusion dependence
💡 Click to Reveal Answer & Nelson Rationale
Option A (Renal papillary necrosis)
Sickle cell trait is usually benign, but certain complications have been reported. These include hematuria, renal papillary necrosis, hyposthenuria, splenic infarction at high altitude, exertional rhabdomyolysis, renal medullary cancer, and microalbuminuria in adults. Renal papillary necrosis is an important high-yield renal complication because the renal medulla has low oxygen tension, high osmolality, and relative acidosis, which favor sickling even in trait.
![[38a44569_1786083930527_1786083932.png]]
A newborn screening hemoglobin analysis shows Hb Bart’s of 20–30%. The infant later has microcytic hypochromic anemia but does not require regular transfusions. Which α-thalassemia genotype best explains this pattern?
---
- (A) One α-globin gene deletion
- (B) Two α-globin gene deletion
- (C) Three α-globin gene deletion
- (D) Four α-globin gene deletion
💡 Click to Reveal Answer & Nelson Rationale
Option C (Three α-globin gene deletion)
Hb Bart’s represents γ-chain tetramers and appears when α-globin chain production is reduced in the newborn period. A three α-globin gene deletion causes hemoglobin H disease, which is characterized by microcytic hypochromic anemia, mild anemia clinically, and newborn Hb Bart’s around 20–30%. Regular transfusions are usually not required in classic HbH disease.
**Table:** The Thalassemias
![[084f9eb7_large_table__2__1786210624.png]]
A 9-year-old child has chronic microcytic anemia with Hb around 7 g/dL but has never required regular transfusions. He has hepatosplenomegaly and mild growth failure. MRI shows iron overload despite only occasional transfusions. Which mechanism best explains the iron overload in this condition?
---
- (A) Repeated transfusions from infancy
- (B) Increased gastrointestinal iron absorption
- (C) Hemolysis-induced urinary iron retention
- (D) Defective iron export due to ferroportin loss
💡 Click to Reveal Answer & Nelson Rationale
Option B (Increased gastrointestinal iron absorption)
This child has features of non–transfusion-dependent thalassemia, also called β-thalassemia intermedia. Unlike thalassemia major, these patients are not chronically transfused from infancy, because the α–β globin chain imbalance is less severe. However, they still have significant ineffective erythropoiesis, which suppresses hepcidin and increases intestinal iron absorption. Therefore, iron overload can develop even with few or no transfusions. This is an important distinction from transfusion-dependent thalassemia, where iron overload is mainly transfusional.
A 6-year-old child presents with acute pallor, jaundice, dark urine, and splenomegaly. Hb is 5.8 g/dL with marked polychromasia and spherocytes on peripheral smear. DAT is strongly positive. Platelet count is normal. Which of the following best describes the usual mechanism of hemolysis in this condition?
---
- (A) IgM-mediated complement fixation with intravascular hemolysis
- (B) IgG-mediated coating of RBCs with splenic extravascular destruction
- (C) IgG-mediated RBC destruction primarily in the liver
- (D) C3 fragment deposition on RBCs as the primary mechanism
💡 Click to Reveal Answer & Nelson Rationale
Option B (IgG-mediated coating of RBCs with splenic extravascular destruction)
This child has warm autoimmune hemolytic anemia, suggested by acute hemolysis, splenomegaly, spherocytes, polychromasia, and a strongly positive DAT. Warm antibodies are usually IgG, active at body temperature, and bind to RBC surface antigens. These IgG-coated RBCs are removed mainly by macrophages in the spleen, causing extravascular hemolysis. Complement fragments such as C3 may sometimes be detected along with IgG, but the usual dominant mechanism is IgG-mediated splenic destruction. When IgG is present in exceptional quantity, it can fix complement, which results in intravascular hemolysis.
A 5-year-old child develops sudden dark urine and pallor after playing outdoors in cold weather. He had a viral illness one week earlier. Laboratory evaluation shows acute intravascular hemolysis. The suspected antibody binds to RBCs at low temperature and causes complement-mediated lysis when the blood warms to 37°C. Which antibody best explains this condition?
---
- (A) IgM anti-I antibody
- (B) IgM anti-i antibody
- (C) IgG anti-P antibody
- (D) IgG anti-Rh antibody
💡 Click to Reveal Answer & Nelson Rationale
Option C (IgG anti-P antibody)
This child has paroxysmal cold hemoglobinuria, which is mediated by the Donath-Landsteiner hemolysin. It is an IgG cold-reactive autoantibody with anti-P specificity. The antibody binds to RBCs in the cold, and complement-mediated hemolysis occurs when the blood warms to 37°C. This explains hemoglobinuria after cold exposure. Most current cases are self-limited and follow nonspecific viral infections.
A child develops acute hemolysis after receiving a drug. DAT is positive with anti-C3, and hemolysis is predominantly intravascular. Which mechanism of drug-induced immune hemolysis best explains this pattern?
---
- (A) Drug adsorption with IgG-mediated extravascular hemolysis
- (B) Ternary immune-complex hemolysis
- (C) True autoantibody induction with IgG-mediated hemolysis
- (D) Nonimmune oxidant hemolysis with bite cells
💡 Click to Reveal Answer & Nelson Rationale
Option B (Ternary immune-complex hemolysis)
In drug-induced immune hemolytic anemia, the DAT pattern and site of hemolysis help identify the mechanism. Ternary immune-complex hemolysis is characterized by a positive DAT with anti-C3 and predominantly intravascular hemolysis. Drugs in this category include cephalosporins, quinidine, amphotericin B, rifampin, metformin, quinine, probenecid, chlorpromazine, and oxaliplatin.
**Table:** Selected Drugs That Cause Immune-Mediated Hemolysis
![[928833c3_medium_table__3__1786210759.png]]
A 12-year-old child is found to have a prolonged aPTT during preoperative screening. He is otherwise healthy and has no history of thrombosis, bleeding, fetal loss history in family, livedo, or autoimmune disease. Lupus anticoagulant is positive once, and he had a viral illness 2 weeks earlier. Which statement is most appropriate?
---
- (A) APS is diagnosed because lupus anticoagulant is positive
- (B) Long-term anticoagulation should be started
- (C) The antibody is likely transient
- (D) Catastrophic APS should be suspected because aPTT is prolonged
💡 Click to Reveal Answer & Nelson Rationale
Option C (The antibody is likely transient)
The image summarizes the Sydney investigational criteria for antiphospholipid syndrome. A diagnosis of definite APS requires at least one clinical criterion and at least one laboratory criterion. Clinical criteria include vascular thrombosis or pregnancy morbidity. Laboratory criteria require persistent antiphospholipid antibody positivity, such as lupus anticoagulant or medium/high-titer anticardiolipin or anti-β2 glycoprotein I antibodies, on two or more occasions at least 12 weeks apart.
**Table: **Sydney Investigational Criteria for the Diagnosis of the Antiphospholipid Syndrome
![[fc8926b5_medium_table__4__1786210866.png]]
Warfarin embryopathy is suspected in a newborn whose mother received oral anticoagulation during the first trimester of pregnancy. Which clinical-radiological feature would most strongly support the diagnosis?
---
- (A) Nasal hypoplasia with epiphyseal and vertebral stippled calcifications
- (B) Midface hypoplasia with proximal limb shortening and trident hands
- (C) Cataract, patent ductus arteriosus, and sensorineural hearing loss
- (D) Craniosynostosis with broad thumbs and broad great toes
💡 Click to Reveal Answer & Nelson Rationale
Option A (Nasal hypoplasia with epiphyseal and vertebral stippled calcifications)
Warfarin embryopathy is classically associated with first-trimester warfarin exposure. It causes bone and cartilage abnormalities known as chondrodysplasia punctata. The high-yield clinical clue is nasal hypoplasia, and the radiological clue is stippled calcification of epiphyses and vertebrae.
Large platelets may be seen in all of the following inherited platelet disorders except
---
- (A) Bernard-Soulier syndrome
- (B) Hermansky-Pudlak syndrome
- (C) Platelet-type von Willebrand disease
- (D) Velocardiofacial/DiGeorge syndrome with GP1BB deletion
💡 Click to Reveal Answer & Nelson Rationale
Option B (Hermansky-Pudlak syndrome)
Large platelets are seen in several inherited platelet adhesion disorders, especially those involving the GPIb-IX-V complex. Bernard-Soulier syndrome, 22q11.2 deletion involving GP1BB, and platelet-type von Willebrand disease may all show thrombocytopenia with large platelets. Hermansky-Pudlak syndrome, however, is a platelet storage pool disorder due to decreased or absent δ-granules, classically associated with oculocutaneous albinism and defective ATP release, not large platelets.
A term neonate develops diffuse petechiae and purpura within a few hours of birth. Platelet count is 12 × 10⁹/L. The mother is clinically well, has no history of thrombocytopenia, and her platelet count is normal. There is no fever, hepatosplenomegaly, or evidence of congenital infection. Neonatal alloimmune thrombocytopenia is suspected. Which investigation would most directly support the diagnosis?
---
- (A) Detection of maternal antiplatelet autoantibodies against maternal platelets
- (B) Detection of maternal alloantibodies directed against paternal platelet antigens
- (C) Detection of neonatal antiplatelet antibodies against maternal platelet antigens
- (D) Detection of maternal anti-HLA antibodies without platelet-specific alloantibodies
💡 Click to Reveal Answer & Nelson Rationale
Option B (Detection of maternal alloantibodies directed against paternal platelet antigens)
This presentation is typical of neonatal alloimmune thrombocytopenia. The mother is usually healthy with a normal platelet count, but she forms IgG alloantibodies against a fetal platelet antigen inherited from the father. These antibodies cross the placenta and destroy fetal/neonatal platelets. The diagnosis is supported by detecting maternal alloantibodies directed against paternal platelet antigens. The most common implicated platelet alloantigen is HPA-1a.
A 7-year-old child with suspected splenic hypofunction is evaluated after recurrent infections with encapsulated organisms. Peripheral smear does not clearly establish the degree of splenic dysfunction. The physician wants a test that can quantify splenic filtering function over a wide range and correlates well with radionuclide methods. Which diagnostic technique is most appropriate?
---
- (A) Detection of Howell-Jolly bodies by staining
- (B) Detection of pitted erythrocytes by phase-interference microscopy
- (C) Technetium-99m sulfur colloid scintiscan
- (D) Enumeration of IgM memory B cells
💡 Click to Reveal Answer & Nelson Rationale
Option B (Detection of pitted erythrocytes by phase-interference microscopy)
Detection of pitted erythrocytes by phase-interference microscopy is a useful test for splenic hypofunction. Pitted erythrocytes are red cells with membrane indentations, and counts allow a wide range of measurements that correlate with radioisotopic methods. This makes it more quantitative than simply looking for Howell-Jolly bodies on smear.
![[44a61694_1786085198682_1786085201.png]]
Which of the following is the most common inherited bone marrow failure syndrome in children?
---
- (A) Dyskeratosis congenita
- (B) Shwachman-Diamond syndrome
- (C) Fanconi anemia
- (D) Diamond-Blackfan anemia
💡 Click to Reveal Answer & Nelson Rationale
Option C (Fanconi anemia)
Fanconi anemia (FA) is the most common inherited bone marrow failure syndrome. It is an autosomal recessive DNA repair defect characterized by progressive pancytopenia, congenital anomalies (short stature, thumb/radial defects, skin pigmentation changes), and predisposition to acute myeloid leukemia and solid tumors.
Which of the following is the most common cause of acquired aplastic anemia in children worldwide?
---
- (A) Idiopathic/immune-mediated
- (B) Benzene exposure
- (C) Viral hepatitis (non-A, non-B, non-C)
- (D) Inherited telomere biology disorders
💡 Click to Reveal Answer & Nelson Rationale
Option A (Idiopathic/immune-mediated)
In the majority (≈70–80%) of pediatric cases, aplastic anemia is idiopathic, often mediated by immune T-cell destruction of hematopoietic stem cells. It is the most common etiology globally.
Which of the following is the most common primary immunodeficiency worldwide?
---
- (A) Severe Combined Immunodeficiency (SCID)
- (B) Common Variable Immunodeficiency (CVID)
- (C) Selective IgA Deficiency
- (D) Chronic Granulomatous Disease (CGD)
💡 Click to Reveal Answer & Nelson Rationale
Option C (Selective IgA Deficiency)
The correct answer is Selective IgA Deficiency. It is the most common primary immunodeficiency worldwide, with a prevalence ranging from 1:300 to 1:3000 depending on the population. Many patients are asymptomatic, while some present with recurrent respiratory tract infections, gastrointestinal infections, or autoimmune conditions.
Which of the following best describes the underlying pathophysiology of Thrombotic Thrombocytopenic Purpura (TTP)?
---
- (A) Autoantibody-mediated deficiency of ADAMTS13 leading to accumulation of ultra-large vWF multimers
- (B) Platelet glycoprotein IIb/IIIa receptor mutation leading to impaired platelet aggregation
- (C) Autoantibody-mediated destruction of platelets in the spleen
- (D) Complement-mediated lysis of red blood cells due to CD55/CD59 deficiency
💡 Click to Reveal Answer & Nelson Rationale
Option A (Autoantibody-mediated deficiency of ADAMTS13 leading to accumulation of ultra-large vWF multimers)
The correct answer is autoantibody-mediated deficiency of ADAMTS13. In TTP, inhibitory autoantibodies against ADAMTS13 (a metalloprotease) lead to markedly reduced activity. This enzyme normally cleaves ultra-large von Willebrand factor multimers, and when deficient, these multimers accumulate and cause widespread platelet aggregation in small vessels, leading to microangiopathic hemolytic anemia and thrombocytopenia.
Which of the following is the most common cause of nutritional anemia worldwide in children?
---
- (A) Iron deficiency
- (B) Folate deficiency
- (C) Vitamin B12 deficiency
- (D) Combined folate and B12 deficiency
💡 Click to Reveal Answer & Nelson Rationale
Option A (Iron deficiency)
Iron deficiency is by far the most prevalent nutritional cause of anemia globally, particularly in infants, young children and adolescent girls. The reasons are multifactorial: inadequate dietary intake of bioavailable iron (especially when diets rely on plant sources), increased physiologic requirements during periods of rapid growth, and blood losses (e.g., hookworm infection, chronic gastrointestinal blood loss, heavy menstrual bleeding in adolescents). Biologically, depleted iron stores lead first to reduced ferritin, then to impaired hemoglobin synthesis causing microcytosis and hypochromia; clinically this produces fatigue, pallor, reduced exercise tolerance and in severe/longstanding cases developmental and cognitive effects in children.
Which laboratory finding is most characteristic of iron deficiency anemia?
---
- (A) Macrocytosis and hypersegmented neutrophils
- (B) Low serum ferritin and high TIBC
- (C) Elevated LDH and indirect bilirubin
- (D) Increased MCV with low reticulocyte count
💡 Click to Reveal Answer & Nelson Rationale
Option B (Low serum ferritin and high TIBC)
Low serum ferritin with an elevated total iron-binding capacity (TIBC) is the classic biochemical signature of iron deficiency. Ferritin reflects body iron stores and falls early in iron depletion; TIBC (a surrogate for transferrin availability) rises because the liver increases transferrin production when iron is scarce. Together these changes (often accompanied by low serum iron and low transferrin saturation) point strongly to iron-deficient erythropoiesis before frank anemia becomes severe.
Which vitamin deficiency classically leads to subacute combined degeneration of the spinal cord?
---
- (A) Folate
- (B) Vitamin B12
- (C) Vitamin C
- (D) Vitamin D
💡 Click to Reveal Answer & Nelson Rationale
Option B (Vitamin B12)
Vitamin B12 (cobalamin) deficiency can cause neurologic dysfunction termed subacute combined degeneration, involving demyelination of the dorsal (posterior) columns and lateral corticospinal tracts. Clinically this manifests as paresthesias, loss of vibration/position sense, spasticity or gait ataxia, and, if untreated, progressive and sometimes irreversible neurologic damage. The pathophysiology relates to impaired myelin maintenance owing to disrupted methylation reactions and accumulation of methylmalonic acid.
Which of the following foods provides the most bioavailable source of iron?
---
- (A) Spinach
- (B) Milk
- (C) Chicken liver
- (D) Pulses
💡 Click to Reveal Answer & Nelson Rationale
Option C (Chicken liver)
Chicken liver (and other organ meats, red meat, and fish) supplies heme iron, which is absorbed far more efficiently (and less influenced by dietary inhibitors) than non-heme iron from plant sources. Heme iron is taken up intact by enterocytes and contributes significantly to improving iron status; organ meats are also rich in other micronutrients such as vitamin A and B12, which can be helpful in malnutrition.
Which of the following laboratory findings is most indicative of classic (severe) hemophilia A?
---
- (A) Prolonged bleeding time, normal PT, prolonged aPTT
- (B) Normal bleeding time, normal PT, prolonged aPTT
- (C) Normal bleeding time, prolonged PT, normal aPTT
- (D) Prolonged bleeding time, prolonged PT, normal aPTT
💡 Click to Reveal Answer & Nelson Rationale
Option B (Normal bleeding time, normal PT, prolonged aPTT)
The correct answer is B. Normal bleeding time, normal PT, prolonged aPTT. Hemophilia A is a deficiency of factor VIII (intrinsic pathway). It does not affect platelet function (so bleeding time is normal), and does not involve the extrinsic pathway (so PT is normal). The intrinsic pathway defect prolongs the activated partial thromboplastin time (aPTT). This classic lab pattern helps distinguish hemophilia from disorders affecting the extrinsic pathway or platelet function.
Which of the following is the most common inherited coagulation disorder worldwide?
---
- (A) Hemophilia A
- (B) Hemophilia B
- (C) von Willebrand disease
- (D) Factor VII deficiency
💡 Click to Reveal Answer & Nelson Rationale
Option C (von Willebrand disease)
von Willebrand disease (vWD) is the most common inherited bleeding disorder, with a prevalence of up to 1% in the general population. It results from quantitative or qualitative defects in von Willebrand factor, affecting both platelet adhesion and factor VIII stability. While hemophilia A is more clinically recognized, vWD is far more frequent.
The most common genetic defect responsible for β-thalassemia major in India is:
---
- (A) IVS 1-5 (G→C)
- (B) Fr 8/9 (+G)
- (C) 619 bp deletion
- (D) Cap +1 (A→C)
💡 Click to Reveal Answer & Nelson Rationale
Option A (IVS 1-5 (G→C))
In India, the IVS 1-5 (G→C) mutation in the β-globin gene is the most common cause of β-thalassemia major. It is a point mutation in the first intervening sequence (intron 1), which leads to abnormal splicing of β-globin mRNA and results in absent or severely reduced β-chain synthesis. This defective mRNA splicing produces a β⁰-thalassemia phenotype when homozygous or in compound heterozygous states, leading to transfusion-dependent thalassemia major. Multiple Indian population studies confirm IVS 1-5 (G→C) accounts for 30–50% of β-thalassemia alleles, making it the single most prevalent mutation in the Indian subcontinent.
A 12-year-old child with thalassemia major will be diagnosed with osteoporosis when:
---
- (A) BMD Z-score > 2.0
- (B) BMD Z-score < 2.0
- (C) BMD Z-score < 2.0 with any bone fracture in absence of trauma
- (D) BMD Z-score < 2.0 with 3 or more than 3 long bone fractures in absence of trauma
💡 Click to Reveal Answer & Nelson Rationale
Option D (BMD Z-score < 2.0 with 3 or more than 3 long bone fractures in absence of trauma)
In children with thalassemia, bone morbidity including osteoporosis is common due to marrow expansion, endocrine dysfunction, and chelation-related effects. The diagnosis of osteoporosis in pediatrics is not based on BMD Z-score alone. According to the IAP-PHO 2023 Guidelines, osteoporosis is diagnosed when there is: A BMD Z-score ≤ –2.0, AND A history of clinically significant fractures (≥ 2 long bone fractures before age 10 years, or ≥ 3 long bone fractures up to age 19 years). This stricter definition prevents overdiagnosis of osteoporosis in growing children where low bone mass may not always indicate pathological bone fragility. In this case, option D correctly reflects the diagnostic criteria.
Voxelotor is a novel therapy approved for sickle cell disease. What is its primary mechanism of action?
---
- (A) Reduces oxidative stress
- (B) Allosterically increases the oxygen affinity of hemoglobin S
- (C) P-selectin inhibitor that blocks adhesion of sickled cells to endothelium
- (D) Increases production of HbF
💡 Click to Reveal Answer & Nelson Rationale
Option B (Allosterically increases the oxygen affinity of hemoglobin S)
Voxelotor is a hemoglobin S polymerization inhibitor. It binds allosterically to HbS, increasing its oxygen affinity, which stabilizes the oxygenated form of hemoglobin and prevents sickling of red blood cells. By reducing polymerization, it decreases hemolysis, improves hemoglobin levels, and reduces anemia in patients with sickle cell disease.
Which of the following is a recognized complication of HbAS (sickle cell trait) under extreme physiological stress?
---
- (A) Stroke secondary to moyamoya disease
- (B) Aplastic crisis due to parvovirus B19
- (C) Recurrent vaso-occlusive pain crises
- (D) Splenic infarction at high altitude
💡 Click to Reveal Answer & Nelson Rationale
Option D (Splenic infarction at high altitude)
Although individuals with sickle cell trait (HbAS) are usually asymptomatic, under conditions of extreme hypoxia, dehydration, or high altitude, sickling of red blood cells can occur, leading to splenic infarction. This is the classic acute complication seen in HbAS when oxygen tension is low, such as during high-altitude exposure or severe hypoxic stress.
All of the following contribute to high HbF and a clinically milder phenotype in sickle cell disease (SCD), except:
---
- (A) BCL11A silencing
- (B) Gamma-Delta-Beta deletion on beta-globin locus
- (C) XmnI polymorphism
- (D) Valine substitution on beta-globin chain at position 6
💡 Click to Reveal Answer & Nelson Rationale
Option D (Valine substitution on beta-globin chain at position 6)
The Valine substitution at position 6 of the β-globin chain (Glu→Val) is the primary mutation responsible for sickle hemoglobin (HbS). It causes sickling and is not associated with higher HbF levels or a milder phenotype. In fact, this mutation is the basis of the disease itself. Mechanisms contributing to higher HbF and milder disease: A) BCL11A silencing: BCL11A is a transcriptional repressor of γ-globin. Silencing or reduced expression leads to higher HbF production, ameliorating sickling. B) Gamma-Delta-Beta deletion: Certain delta-beta or gamma-delta-beta globin gene deletions result in hereditary persistence of fetal hemoglobin (HPFH), increasing HbF levels. C) XmnI polymorphism: This promoter polymorphism in the γ-globin gene is associated with higher HbF expression, leading to milder SCD symptoms.
A 12-year-old girl with HbSS on routine follow-up (median Hb 10 g/dL) presents with hemoglobin 6 g/dL, pallor, hypotension, and massive splenomegaly. What is the next best line of treatment?
---
- (A) Rapid hydration and hydroxyurea initiation
- (B) Transfusion with PRBC to Hb of 8 g/dL
- (C) Transfusion to Hb 10–12 g/dL
- (D) Transfusion and immediate splenectomy
💡 Click to Reveal Answer & Nelson Rationale
Option B (Transfusion with PRBC to Hb of 8 g/dL)
This patient is presenting with acute splenic sequestration, a life-threatening complication of HbSS, characterized by: Rapid drop in hemoglobin Massive splenomegaly Hypotension or shock Management: Careful transfusion with PRBCs to raise Hb to ~8 g/dL is recommended. Rapid over-transfusion (target Hb 10–12 g/dL) should be avoided as it can increase blood viscosity and precipitate vaso-occlusive crises or stroke. Splenectomy is reserved for recurrent episodes, not the initial acute event.
Which of the following does not contribute to the “masking effect” in hereditary spherocytosis (HS)?
---
- (A) Nutritional anemia
- (B) Iron deficiency
- (C) Cholestasis
- (D) HbAS
💡 Click to Reveal Answer & Nelson Rationale
Option D (HbAS)
The masking effect in hereditary spherocytosis refers to factors that reduce the typical laboratory or clinical manifestations of HS (e.g., hemolysis, anemia, reticulocytosis). HbAS (sickle cell trait) does not alter the HS phenotype or mask its laboratory findings. Therefore, it is not a contributing factor to masking in HS. Mechanisms of masking in HS: A) Nutritional anemia: Reduces baseline hemoglobin, making hemolysis less obvious. B) Iron deficiency: Lowers mean corpuscular volume and can reduce spherocyte visibility on the peripheral smear. C) Cholestasis: Can alter bilirubin metabolism, reducing clinical jaundice and masking hemolysis.
In a patient with Pyruvate Kinase (PK) deficiency, the primary pathophysiological mechanism leading to hemolysis is:
---
- (A) Accumulation of methemoglobin due to defect in the MetHb reductase pathway
- (B) Reduced NADPH production leading to increased oxidative stress
- (C) Failure of ion pump leading to water accumulation and cell lysis
- (D) Insufficient ATP production leading to failure of the cation pump and dehydration of the red cell
💡 Click to Reveal Answer & Nelson Rationale
Option D (Insufficient ATP production leading to failure of the cation pump and dehydration of the red cell)
In Pyruvate Kinase (PK) deficiency, RBCs cannot generate adequate ATP because PK catalyzes the final ATP-producing step of glycolysis (phosphoenolpyruvate → pyruvate). RBCs depend entirely on glycolysis for energy, so ATP depletion causes failure of the Na⁺/K⁺-ATPase pump, leading to potassium and water loss, cell dehydration, formation of echinocytes, and premature splenic destruction (extravascular hemolysis).
A 10-year-old girl has menorrhagia and easy bruising since early childhood. Labs: CBC normal (platelets 280×10^9/L), prolonged bleeding time, and platelet light-transmission aggregometry shows: no aggregation with ADP, collagen or epinephrine; normal aggregation with low-dose ristocetin; platelet surface CD41 (GPIIb) expression is markedly reduced on flow cytometry. Which is the best statement?
---
- (A) The findings are most consistent with Bernard-Soulier syndrome (GPIb deficiency).
- (B) The findings are most consistent with Glanzmann thrombasthenia (GPIIb/IIIa deficiency).
- (C) The findings suggest type 1 von Willebrand disease.
- (D) The pattern is typical of platelet dense-granule storage pool deficiency.
💡 Click to Reveal Answer & Nelson Rationale
Option B (The findings are most consistent with Glanzmann thrombasthenia (GPIIb/IIIa deficiency).)
This is a defect of platelet GPIIb/IIIa (integrin αIIbβ3), leading to defective fibrinogen binding and platelet aggregation. Classic lab pattern: absent aggregation with multiple agonists but normal ristocetin response. Flow cytometry confirms diagnosis by reduced CD41/CD61 expression.
A 7-year-old boy presents with pallor, recurrent infections, and easy bruising. On exam: short stature, café-au-lait spots, hypoplastic thumbs. CBC: pancytopenia. Bone marrow: hypocellular. Which inherited bone marrow failure syndrome best explains this presentation?
---
- (A) Fanconi anemia
- (B) Diamond-Blackfan anemia
- (C) Dyskeratosis congenita
- (D) Shwachman-Diamond syndrome
💡 Click to Reveal Answer & Nelson Rationale
Option A (Fanconi anemia)
The combination of pancytopenia, congenital anomalies (thumb/radial defects, short stature, skin pigmentation), and hypocellular marrow is classic for Fanconi anemia. Chromosomal breakage studies confirm the diagnosis.
A 14-year-old boy presents with progressive nail dystrophy, leukoplakia in the oral cavity, and abnormal skin pigmentation. CBC shows pancytopenia. Bone marrow is hypocellular. Telomere length analysis is markedly reduced. What is the most likely diagnosis?
---
- (A) Diamond-Blackfan anemia
- (B) Dyskeratosis congenita
- (C) Shwachman-Diamond syndrome
- (D) Fanconi anemia
💡 Click to Reveal Answer & Nelson Rationale
Option B (Dyskeratosis congenita)
This telomere biology disorder is characterized by the mucocutaneous triad (nail dystrophy, oral leukoplakia, abnormal skin pigmentation) along with progressive marrow failure. Short telomeres on testing confirm the diagnosis.
A 9-year-old girl presents with fatigue, recurrent epistaxis, and petechiae. CBC: Hb 7 g/dL, ANC 300/µL, Platelets 12 ×10^9/L, MCV normal. Bone marrow biopsy: cellularity <20%. She has no skeletal anomalies, skin pigmentation, or family history of marrow failure. What is the most likely diagnosis?
---
- (A) Fanconi anemia
- (B) Acquired aplastic anemia
- (C) Diamond-Blackfan anemia
- (D) Shwachman-Diamond syndrome
💡 Click to Reveal Answer & Nelson Rationale
Option B (Acquired aplastic anemia)
The vignette shows pancytopenia + hypocellular marrow without congenital anomalies, consistent with acquired idiopathic aplastic anemia. Absence of syndromic features rules out inherited marrow failure syndromes.
A 3-year-old boy presents with recurrent otitis media, chronic diarrhea, and failure to thrive. He has absent tonsils and lymph nodes on examination. CBC: normal WBC count. Serum immunoglobulins: IgG, IgA, IgM all markedly reduced. What is the most likely diagnosis?
---
- (A) X-linked agammaglobulinemia (XLA)
- (B) Severe Combined Immunodeficiency (SCID)
- (C) Common Variable Immunodeficiency (CVID)
- (D) Hyper-IgE Syndrome
💡 Click to Reveal Answer & Nelson Rationale
Option A (X-linked agammaglobulinemia (XLA))
The correct answer is X-linked agammaglobulinemia (XLA). This condition results from a mutation in the BTK gene, leading to defective B-cell maturation. Children present after 6 months of age (when maternal IgG wanes) with recurrent bacterial infections, diarrhea, and failure to thrive. The absence of lymphoid tissue such as tonsils and lymph nodes is a key clinical clue, and laboratory findings reveal markedly reduced levels of all immunoglobulin classes.
A 2-year-old boy presents with recurrent pneumonia and lymphadenopathy. The photograph shows a child with partial albinism, silvery hair, and hepatosplenomegaly. Blood smear shows giant cytoplasmic granules in neutrophils. What is the most likely diagnosis?
---
- (A) Wiskott–Aldrich Syndrome
- (B) Chronic Granulomatous Disease
- (C) Chediak–Higashi Syndrome
- (D) Ataxia–Telangiectasia
💡 Click to Reveal Answer & Nelson Rationale
Option C (Chediak–Higashi Syndrome)
The correct answer is Chediak–Higashi Syndrome. This rare autosomal recessive disorder is caused by mutations in the LYST gene, which leads to defective lysosomal trafficking. Clinically, children present with oculocutaneous albinism, silvery hair, recurrent pyogenic infections, hepatosplenomegaly, and lymphadenopathy. On peripheral smear, pathognomonic giant cytoplasmic granules are seen in neutrophils and other leukocytes.
A 14-year-old girl presents with fever, confusion, and petechiae. On examination, she has pallor, mild jaundice, and neurological irritability. Laboratory findings reveal Hb 7 g/dL, Platelets 18 ×10^9/L, creatinine 2.1 mg/dL, and LDH markedly elevated. Peripheral smear shows schistocytes. What is the most likely diagnosis?
---
- (A) Immune Thrombocytopenic Purpura (ITP)
- (B) Hemolytic Uremic Syndrome (HUS)
- (C) Thrombotic Thrombocytopenic Purpura (TTP)
- (D) Acute Lymphoblastic Leukemia (ALL)
💡 Click to Reveal Answer & Nelson Rationale
Option C (Thrombotic Thrombocytopenic Purpura (TTP))
The correct answer is Thrombotic Thrombocytopenic Purpura (TTP). This vignette highlights the classic pentad: fever, neurological symptoms, thrombocytopenia, microangiopathic hemolytic anemia (schistocytes, high LDH), and renal dysfunction. Although not all features are always present, the combination of thrombocytopenia, hemolysis, neurological signs, and renal impairment strongly supports TTP.
7-year-old boy with pallor/fatigue. Hb 7 g/dL, MCV 68 fL, ferritin 8 ng/mL. Most likely diagnosis?
---
- (A) Iron deficiency
- (B) Folate deficiency
- (C) Vitamin B12 deficiency
- (D) Hemolytic anemia
💡 Click to Reveal Answer & Nelson Rationale
Option A (Iron deficiency)
This child’s severe anemia with microcytosis (low MCV) and very low ferritin is typical for iron deficiency. Ferritin reflects iron stores, so a value in the single digits is strongly suggestive of iron depletion. Iron deficiency in children commonly presents with pallor, lethargy, and decreased school performance; confirming the diagnosis allows straightforward therapy (iron replacement and investigation for sources of blood loss or poor intake).
10-yr-old vegetarian girl with anemia, glossitis and paresthesia; Hb 6.5 g/dL, MCV 112 fL, hypersegmented neutrophils. Which deficiency is most likely?
---
- (A) Iron
- (B) B12
- (C) Folate
- (D) Vitamin C
💡 Click to Reveal Answer & Nelson Rationale
Option B (B12)
The combination of macrocytic anemia (high MCV), mucosal change (glossitis) and neurologic symptoms (paresthesia) together with hypersegmented neutrophils is classic for vitamin B12 deficiency. Vegetarians are at increased risk because dietary B12 is primarily from animal products; prolonged deficiency affects both DNA synthesis in erythroid precursors (megaloblastic anemia) and neurologic function (demyelination), so early recognition and replacement are critical to prevent permanent deficits.
15-yr-old with celiac disease: Hb 8.5 g/dL, MCV 110 fL, macro-ovalocytes, hypersegmented neutrophils. Which nutrient deficiency is most likely?
---
- (A) Iron
- (B) Folate
- (C) Vitamin B12
- (D) Vitamin D
💡 Click to Reveal Answer & Nelson Rationale
Option B (Folate)
In celiac disease, malabsorption commonly affects the proximal small intestine where folate is absorbed; chronic malabsorption may therefore lead to folate deficiency and megaloblastic anemia. The morphological findings of macro-ovalocytes and hypersegmented neutrophils are classic for folate (or B12) deficiency, and in the context of celiac disease, folate is the likelier culprit because proximal small bowel is primarily involved.
Child with severe iron deficiency started on oral iron. After 1 week, which change is expected first?
---
- (A) Hb rise
- (B) Ferritin rise
- (C) Reticulocytosis
- (D) Disappearance of pallor
💡 Click to Reveal Answer & Nelson Rationale
Option C (Reticulocytosis)
The earliest hematologic response to effective iron therapy is an increase in reticulocyte count (reticulocytosis), typically seen within 5–7 days as the bone marrow ramps up erythropoiesis. This is a useful early objective marker of treatment response; a subsequent rise in hemoglobin follows over 2–3 weeks, and clinical improvement (less pallor, more energy) becomes more evident thereafter.
Low Hb, low MCV, normal ferritin but reduced transferrin saturation — next best test?
---
- (A) Soluble transferrin receptor (sTfR)
- (B) LDH
- (C) Haptoglobin
- (D) Direct Coombs
💡 Click to Reveal Answer & Nelson Rationale
Option A (Soluble transferrin receptor (sTfR))
The soluble transferrin receptor (sTfR) assay is helpful when ferritin is normal or may be falsely elevated (e.g., inflammatory states) and you need to distinguish iron deficiency from anemia of chronic disease (ACD). sTfR levels rise in iron deficiency (reflecting increased cellular demand for iron and upregulation of transferrin receptors) but remain normal or low in ACD. Thus an elevated sTfR points toward iron deficiency even when ferritin is equivocal.
A 5-year-old boy presents with repeated joint bleeding (hemarthroses) and easy bruising. His mother mentions a maternal uncle had bleeding problems. On lab testing: PT is normal, aPTT is markedly prolonged, mixing studies correct the aPTT, and factor VIII level is <1%. What is the most likely diagnosis?
---
- (A) Acquired hemophilia (autoantibody to factor VIII)
- (B) Hemophilia B (factor IX deficiency)
- (C) Hemophilia A (factor VIII deficiency)
- (D) von Willebrand disease type 2B
💡 Click to Reveal Answer & Nelson Rationale
Option C (Hemophilia A (factor VIII deficiency))
The clinical history (X-linked inheritance — maternal uncle affected, male child), joint bleeding, and lab results point strongly to severe hemophilia A. The fact that mixing the patient’s plasma with normal plasma corrects the prolonged aPTT indicates a deficiency-type, not an inhibitor; and the very low factor VIII level (<1%) is consistent with severe hemophilia A.
In a patient with hemophilia A who develops a high titer inhibitor (neutralizing antibody) to factor VIII, which of the following management strategies is most appropriate for a major bleeding episode?
---
- (A) Give high-dose factor VIII concentrate alone
- (B) Use factor VIII and desmopressin simultaneously
- (C) Use a bypassing agent such as activated prothrombin complex concentrate (aPCC) or recombinant factor VIIa
- (D) Switch to factor IX concentrate
💡 Click to Reveal Answer & Nelson Rationale
Option C (Use a bypassing agent such as activated prothrombin complex concentrate (aPCC) or recombinant factor VIIa)
Use a bypassing agent such as aPCC or recombinant factor VIIa. In patients who have developed a inhibitor (neutralizing antibody) against factor VIII, standard factor VIII replacement will be neutralized by the inhibitor and will not stop bleeding. Bypassing agents circumvent the need for factor VIII by enabling coagulation downstream of the blocked step. These agents are the mainstay in managing bleeding in inhibitor-positive hemophilia A patients.
A 7-year-old boy presents with the pictured knee swelling after minor trauma. He has a known family history of bleeding disorder in maternal male relatives. Labs show prolonged aPTT, normal PT, normal bleeding time. What is the most likely diagnosis?
---
- (A) Immune thrombocytopenic purpura (ITP)
- (B) Hemophilia A
- (C) von Willebrand disease
- (D) Vitamin K deficiency
💡 Click to Reveal Answer & Nelson Rationale
Option B (Hemophilia A)
The photograph shows a classic hemarthrosis, a hallmark of hemophilia. Recurrent joint bleeding leads to painful swelling and eventually chronic arthropathy if untreated. The family history of affected male relatives (X-linked inheritance) and lab profile (prolonged aPTT, normal PT, normal bleeding time) point to hemophilia A. Early recognition is crucial, as factor replacement prevents permanent disability.
A 5-year-old boy presents with recurrent gum bleeds and epistaxis. He has prolonged bleeding time and a mildly prolonged aPTT, with normal PT. His father reports no history of hemarthroses. Which is the most likely diagnosis?
---
- (A) Hemophilia A
- (B) von Willebrand disease
- (C) Glanzmann’s thrombasthenia
- (D) Vitamin K deficiency
💡 Click to Reveal Answer & Nelson Rationale
Option B (von Willebrand disease)
This is a classic presentation of von Willebrand disease. The combination of mucocutaneous bleeding (gum bleeding, epistaxis), prolonged bleeding time, and slightly prolonged aPTT is characteristic. The absence of hemarthrosis makes hemophilia unlikely.
A patient with severe hemophilia A is started on factor VIII replacement therapy. After several infusions, his aPTT remains prolonged and bleeding continues. A mixing study shows no correction. What is the most likely explanation?
---
- (A) He has developed an inhibitor antibody to factor VIII
- (B) He has acquired von Willebrand disease
- (C) He has progressed to hemophilia B
- (D) He is non-compliant with therapy
💡 Click to Reveal Answer & Nelson Rationale
Option A (He has developed an inhibitor antibody to factor VIII)
Failure of a mixing study to correct prolonged aPTT in a hemophilia patient strongly suggests development of an inhibitor antibody against factor VIII. This is a major complication of replacement therapy and occurs in up to 20–30% of severe hemophilia A cases. These inhibitors neutralize both endogenous and infused factor VIII.
A 4-year-old boy is brought to the emergency department with a 2-day history of acute-onset pallor, jaundice, and passing dark "cola-colored" urine. He had a viral illness 10 days earlier. Examination shows fever, tachycardia, and mild hepatosplenomegaly.Laboratory findings: Hemoglobin: 4.2 g/dL, Reticulocyte count: 18%, Peripheral smear: Reticulocytosis, spherocytes, polychromasia, Total bilirubin: 5.8 mg/dL (Indirect 4.9 mg/dL), Direct Antiglobulin Test (DAT): Positive for C3d only; negative for IgGCrossmatch is incompatible with all donor units. What is the most critical step in the management of this patient’s transfusion?
---
- (A) Pre-medication with high-dose IVIG and methylprednisolone before transfusion
- (B) Use of leukocyte-reduced, irradiated, extended antigen-matched PRBCs
- (C) Administration of PRBCs through an in-line blood warmer at 37°C
- (D) Performing plasma exchange prior to transfusion to reduce antibody titer
💡 Click to Reveal Answer & Nelson Rationale
Option C (Administration of PRBCs through an in-line blood warmer at 37°C)
This child’s clinical picture (acute hemolysis after viral illness, DAT positive for complement only) is classic for Paroxysmal Cold Hemoglobinuria (PCH), mediated by the Donath–Landsteiner antibody (a biphasic hemolysin). The antibody binds RBCs at cold temperatures (<20°C) and fixes complement, which is then activated when RBCs return to core temperature, causing massive intravascular hemolysis. Transfusion may be life-saving but must be performed cautiously: the most critical step is to transfuse through an in-line blood warmer to prevent exposure of donor red cells to cold temperatures, minimizing antibody binding and further hemolysis.
A 5-year-old girl with a history of autoimmune hemolytic anemia (AIHA) diagnosed 8 months ago, previously treated with steroids, presents with a repeat episode of hemolysis. She is restarted on prednisolone, but after 1 week of therapy, she continues to require transfusions every 3–4 days. Reticulocyte count is 15%, and DAT remains strongly positive. What is the next best line of management for this child with steroid-refractory AIHA?
---
- (A) IV immunoglobulin (2 g/kg over 3–5 days) with continuation of steroids
- (B) Rituximab weekly for 6 doses
- (C) Splenectomy
- (D) High-dose methylprednisolone
💡 Click to Reveal Answer & Nelson Rationale
Option B (Rituximab weekly for 6 doses)
This child has steroid-refractory AIHA, defined as persistence of clinically significant hemolysis despite adequate steroid therapy. The best next-line treatment is rituximab, an anti-CD20 monoclonal antibody that targets B cells responsible for autoantibody production. Multiple pediatric studies and consensus guidelines now recommend rituximab as the preferred second-line therapy due to its efficacy and favorable safety profile compared to splenectomy. Weekly rituximab infusions for 4–6 weeks can induce sustained remissions in most children with refractory AIHA.
An 11-month-old infant is evaluated for severe microcytic hypochromic anemia (Hb 5.1 g/dL). HPLC analysis shows the following fractions: HbF: 92%, HbA: 0%, HbA₂: 2.5% What is the most probable diagnosis?
---
- (A) Homozygous β⁰-thalassemia
- (B) Homozygous δβ-thalassemia
- (C) Compound heterozygous β-thalassemia / HPFH
- (D) α-thalassemia major
💡 Click to Reveal Answer & Nelson Rationale
Option B (Homozygous δβ-thalassemia)
The hallmark here is absent HbA, nearly complete replacement by HbF, and low/normal HbA₂. In homozygous δβ-thalassemia, both the δ and β genes are deleted, so there is no HbA (α₂β₂) and no HbA₂ (α₂δ₂). The γ-chain genes compensate fully, producing markedly elevated HbF. Thus, the profile of 0% HbA, very high HbF, and low/normal HbA₂ is diagnostic for homozygous δβ-thalassemia.
![[08e23f4b_small__56__1760171092.png]]
A couple undergoes pre-conceptional counseling. The prospective father’s HPLC shows HbA₂ 1.8% and HbF 15%. The prospective mother’s HPLC shows HbA₂ 5.2%.What is the predicted phenotype in a child who inherits the abnormal gene from both parents?
---
- (A) Asymptomatic carrier state
- (B) Mild non–transfusion-dependent thalassemia
- (C) β-thalassemia major
- (D) Hb Lepore–β thalassemia
💡 Click to Reveal Answer & Nelson Rationale
Option C (β-thalassemia major)
The father’s HPLC pattern—low/normal HbA₂ with significantly elevated HbF—is characteristic of δβ-thalassemia trait. The mother’s HPLC pattern—elevated HbA₂—is classic for β-thalassemia trait. If a child inherits the δβ deletion from the father and the β mutation from the mother, the result is a compound heterozygous δβ-thalassemia/β-thalassemia genotype. This leads to an almost complete inability to produce functional β chains. Clinically, such children present with severe transfusion-dependent anemia indistinguishable from β-thalassemia major, requiring lifelong transfusions and chelation.
![[80b90dd8_small__57__1760171398.png]]
A 10-year-old boy with transfusion-dependent thalassemia is treated with deferasirox. His baseline serum creatinine was 0.5 mg/dL, and after one year it has stabilized at 0.7 mg/dL. A urinalysis reveals: Urine pH: 6.5, 1+ glycosuria with normal blood glucose, Positive urine phosphate What is the most likely diagnosis?
---
- (A) Deferasirox-induced acute kidney injury
- (B) Iron-induced glomerular damage
- (C) Proximal renal tubular dysfunction (Fanconi syndrome)
- (D) Coincidental diabetic nephropathy
💡 Click to Reveal Answer & Nelson Rationale
Option C (Proximal renal tubular dysfunction (Fanconi syndrome))
Deferasirox, an oral iron chelator, is well known for renal side effects. A mild, stable increase in creatinine is relatively common and usually benign. However, this boy presents with a combination of normoglycemic glycosuria and phosphaturia, both markers of proximal tubular dysfunction. The inappropriately alkaline urine further supports the diagnosis of Fanconi syndrome, a rare but serious complication of deferasirox therapy. Recognition is crucial, as continued therapy can lead to worsening acidosis, hypophosphatemic rickets, and growth failure. Management requires dose reduction or discontinuation of deferasirox.
7-year-old girl with beta-thalassemia was initially receiving monthly transfusions at a center that performs extended RBC phenotyping and maintains a pretransfusion hemoglobin level of 8–9 g/dL. Over the past 6 months, despite biweekly transfusions, her hemoglobin has been 5–6 g/dL. She experiences early satiety and poor weight gain. Her WBC count is 2,700/mm³ and her platelet count is 55,000/mm³. Which strategy would benefit her?
---
- (A) Transfuse irradiated blood
- (B) Offer splenectomy
- (C) Test for alloimmunization and perform a direct Coombs test
- (D) Immunosuppression with steroids and rituximab
💡 Click to Reveal Answer & Nelson Rationale
Option B (Offer splenectomy)
The recommended transfusion strategy for transfusion-dependent thalassemia is to transfuse PRBC every 2–5 weeks to maintain a pretransfusion hemoglobin level above 9–10.5 g/dL. Extended red cell antigen typing, including ABO, Rh, and Kell antigens, and issuing compatible products reduce the risk of alloimmunization with repeated transfusions. Although leukodepletion is recommended to reduce alloimmunization in thalassemia, irradiation of blood products is not necessary. Irradiation is relevant to reduce the risk of transfusion-associated graft-versus-host disease (GVHD) in immunocompromised patients and in the setting of a bone marrow transplant. The presence of early satiety and pancytopenia suggests symptomatic splenomegaly and hypersplenism, and this patient may benefit from a splenectomy.
A 7-year-old boy with thalassemia major diagnosed at 7 months of age is on a regular transfusion schedule every 21 days. His serum ferritin levels have remained between 2000–3000 ng/mL for the last 2 months. He has been on deferasirox 25 mg/kg/day for the past year.<br id="isPasted"
---
- (A) Start deferiprone and stop deferasirox due to poor response
- (B) Increase dose of deferasirox to 50 mg/kg/day
- (C) Increase dose of deferasirox by 10 mg/kg/day
- (D) Add deferiprone in addition to deferasirox
💡 Click to Reveal Answer & Nelson Rationale
Option C (Increase dose of deferasirox by 10 mg/kg/day)
In children with thalassemia major, persistent hyperferritinemia despite chelation requires stepwise dose escalation of deferasirox (DFX) before considering combination therapy. The recommended approach is to increase the DFX dose by 10 mg/kg/day every 2 months, up to a maximum of 40 mg/kg/day, provided adherence and tolerability are good. In this case, the child is on 25 mg/kg/day; hence the next logical step is escalation to 30–35 mg/kg/day. This is supported by the IAP-PHO 2023 evidence-based guidelines, which emphasize optimizing single-agent therapy before combination chelation.
A 14-year-old boy with thalassemia major, diagnosed at 6 months of age, has been receiving blood transfusions every 15 days for the past 8 months. His serum ferritin is 6000 ng/mL. He is on deferiprone at maximum dose with good compliance. A cardiac MRI shows CMR T2 < 10 ms*. What is the next best line of management?
---
- (A) Add deferasirox at maximum dose immediately and reassess after 2 months
- (B) Add deferasirox and repeat cardiac MRI after 1 year
- (C) Stop deferiprone and start deferoxamine infusion and repeat cardiac MRI in 1 year
- (D) Add deferoxamine infusion in addition to deferiprone and repeat cardiac MRI in 6 months
💡 Click to Reveal Answer & Nelson Rationale
Option D (Add deferoxamine infusion in addition to deferiprone and repeat cardiac MRI in 6 months)
A CMR T2 < 10 ms* is strongly predictive of significant cardiac iron overload and indicates a high risk of developing cardiac decompensation. Patients with T2* < 6 ms have up to a 50% risk of heart failure within 1 year if not aggressively treated. According to IAP-PHO 2023 guidelines and multiple studies, the most effective regimen in this setting is combined chelation therapy with deferiprone (DFP) + deferoxamine (DFO), which has been shown (Level of Evidence 1) to improve cardiac iron clearance and left ventricular ejection fraction better than either drug alone. Reassessment with repeat cardiac MRI in 6 months is recommended to monitor response.
A child with a history of chronic anemia presents with fever and a rash. Laboratory tests show decreased hemoglobin and low reticulocyte count. What type of anemia might be observed in this patient if they have an underlying immunodeficiency?
---
- (A) Chronic pure red cell aplasia (PRCA)
- (B) Iron deficiency anemia
- (C) Anemia of chronic disease
- (D) Hemolytic anemia
💡 Click to Reveal Answer & Nelson Rationale
Option A (Chronic pure red cell aplasia (PRCA))
In patients with immunodeficiency, Parvovirus B19 infection can lead to chronic pure red cell aplasia. The virus specifically infects erythroid precursors in the bone marrow, causing suppression of erythropoiesis, which manifests as anemia with reticulocytopenia. Chronic infection is possible because the immune system cannot clear the virus effectively. Clinically, this may present with fever, rash, and worsening anemia.
A patient with HbSS on chronic transfusion therapy has a serum ferritin of 2500 ng/mL. MRI T2* shows: Liver: severely reduced T2* (high iron load) Heart: normal T2* Which chelation agent would be most appropriate in this scenario?
---
- (A) Deferiprone (DFP)
- (B) Deferasirox (DFX)
- (C) Deferoxamine (DFO)
- (D) DFP + DFX
💡 Click to Reveal Answer & Nelson Rationale
Option B (Deferasirox (DFX))
Deferasirox is highly effective in reducing hepatic iron overload in patients on chronic transfusion therapy. In this patient, the MRI shows severe liver iron accumulation with normal cardiac iron. Therefore, DFX as monotherapy is the most appropriate choice, as it efficiently removes iron from the liver and has convenient oral dosing.
An 8-year-old boy with sickle cell disease presents with fever, severe lower limb pain, swelling, and local warmth. What is the next best step in management?
---
- (A) Hydration, opioids, and antipyretics
- (B) Broad-spectrum antibiotics and MRI
- (C) Broad-spectrum antibiotics, blood/CSF cultures, and aspiration
- (D) MRI, opioids, and antipyretics
💡 Click to Reveal Answer & Nelson Rationale
Option C (Broad-spectrum antibiotics, blood/CSF cultures, and aspiration)
In patients with sickle cell disease, fever with localized pain, swelling, and warmth raises concern for osteomyelitis, particularly caused by Salmonella species or Staphylococcus aureus. The initial management should include: Broad-spectrum IV antibiotics targeting likely pathogens Blood cultures to identify bacteremia Aspiration of joint or bone (if feasible) for culture and confirmation Early recognition and treatment are crucial to prevent progression to chronic infection or sepsis. Imaging (e.g., MRI) may help delineate the extent of infection but should not delay initiation of antibiotics.
A 12-year-old boy with sickle cell disease had an abnormal Transcranial Doppler (TCD
---
- (A) Continue chronic transfusion to maintain Hb ~10 g/dL and HbS <30%
- (B) Stop chronic transfusion and start hydroxyurea
- (C) Start hydroxyurea if TCD <170 cm/s
- (D) Stop all treatment for primary prophylaxis if TCD <180 cm/s and continue regular monitoring
💡 Click to Reveal Answer & Nelson Rationale
Option A (Continue chronic transfusion to maintain Hb ~10 g/dL and HbS <30%)
Patients with abnormal TCD velocities (>200 cm/s) are at high risk of stroke. Evidence from the STOP trial and subsequent studies shows that regular chronic transfusions are the most effective primary prophylaxis to reduce stroke risk. The goal is to: Maintain hemoglobin ~10 g/dL Reduce HbS to <30% This regimen significantly decreases the risk of first stroke in children with sickle cell disease. TCD monitoring should continue during transfusions to guide therapy.
A 7-year-old boy has been diagnosed with chronic immune thrombocytopenia (ITP) for 12 months, with thrombocytopenia, occasional mucosal bleeding, and epistaxis. He was previously treated with steroids and IVIG but only had transient responses. He now presents with schymotic patches and hematemesis. What is the best line of second-line therapy?
---
- (A) High-dose methylprednisolone (MPS)
- (B) Rituximab
- (C) Thrombopoietin receptor agonist (TPO-RA)
- (D) Plasmapheresis
💡 Click to Reveal Answer & Nelson Rationale
Option B (Rituximab)
This child has chronic ITP that is refractory to first-line therapy (steroids and IVIG) and is now presenting with significant bleeding (hematemesis, extensive bruising). Rituximab, an anti-CD20 monoclonal antibody, targets B cells producing pathogenic autoantibodies against platelets and is considered first-choice second-line therapy in pediatric chronic ITP. It is effective in raising platelet counts and reducing bleeding risk in refractory patients.
An 8-year-old boy presents to the emergency department with abrupt-onset petechial purpura and mild gum bleeding within the last 24 hours. He is afebrile, with no organomegaly or lymphadenopathy. CBC shows isolated thrombocytopenia. What is the most appropriate initial management?
---
- (A) Observe the patient closely and reassure parents
- (B) Initiate high-dose steroids
- (C) Initiate IVIG
- (D) Platelet transfusion
💡 Click to Reveal Answer & Nelson Rationale
Option A (Observe the patient closely and reassure parents)
This child has acute immune thrombocytopenia (ITP), presenting with mild mucocutaneous bleeding and isolated thrombocytopenia. In pediatric acute ITP, most children are hemodynamically stable and have minor bleeding. Observation alone is appropriate in mild cases with platelet counts usually >10,000–20,000/µL and no severe bleeding. Spontaneous platelet recovery occurs in most children within weeks, and invasive therapy is not required initially.
A newborn presents with severe hemolytic anemia requiring exchange transfusion. Peripheral smear shows fragmented RBCs and numerous microspherocytes. Osmotic fragility is severely abnormal, and flow cytometry confirms significant Band 3 deficiency. What is the most appropriate long-term management strategy?
---
- (A) Regular blood transfusions and chelation therapy
- (B) Bone marrow transplantation
- (C) Splenectomy after 6 years of age
- (D) High-dose steroids and immunomodulation
💡 Click to Reveal Answer & Nelson Rationale
Option C (Splenectomy after 6 years of age)
This patient has severe hereditary spherocytosis (HS) with confirmed Band 3 deficiency. Splenectomy is the definitive long-term management for severe HS, as it reduces hemolysis by removing the primary site of red cell destruction. In children, splenectomy is generally delayed until after 6 years of age to reduce the risk of post-splenectomy infections while balancing the need to prevent ongoing hemolysis and complications (e.g., growth retardation, gallstones). Supportive care (folate supplementation, transfusions) is used until splenectomy if anemia is significant.
A 1-year-old male child presents with a new onset of severe anemia, petechiae, and epistaxis. Laboratory evaluation reveals platelet count of 8000/µL, hemoglobin of 5.5 g/dL, and reticulocyte count of 10%. The peripheral smear shows microspherocytes, fragmented red cells, and reticulocytosis along with thrombocytopenia. Which is the most likely diagnosis?
---
- (A) HUS
- (B) ITP
- (C) TTP
- (D) Evans syndrome
💡 Click to Reveal Answer & Nelson Rationale
Option A (HUS)
The child presents with severe anemia, thrombocytopenia, fragmented RBCs (schistocytes), and elevated reticulocyte count, which are classic for microangiopathic hemolytic anemia (MAHA). In a 1-year-old, the most common cause of MAHA with thrombocytopenia is Hemolytic Uremic Syndrome (HUS).HUS is defined by the triad of: Microangiopathic hemolytic anemia (MAHA) – schistocytes, elevated LDH, high reticulocytes Thrombocytopenia – due to platelet consumption in microthrombi Acute kidney injury – may develop later (not always initially evident)It is most commonly seen after E. coli O157:H7 infection producing Shiga toxin. Early recognition and supportive management (hydration, renal monitoring) are essential.
A case of T-Acute Lymphoblastic Leukemia with total lymphocyte count of 4 lakhs and a mediastinal mass causing Superior Vena Cava (SVC) syndrome presents to the pediatric emergency room with the following laboratory values: K⁺: 5.5 mmol/L, Uric acid: 15.5 mg/dL, Calcium: 9.0 mg/dL, Phosphorus: 7 mg/dL, Creatinine: 1.2 mg/dL The child was promptly treated with hydration and Inj. Rasburicase. The next morning, the child develops severe pallor, hematuria, and signs of congestive heart failure (CHF). What is the most likely diagnosis and management of this complication?
---
- (A) Tumor lysis syndrome (TLS)-induced tubular damage, continue same management
- (B) G6PD deficiency, supportive care and packed cell transfusion
- (C) Renal infiltration of leukemia, start steroid immediately
- (D) Thrombocytopenia and DIC, transfuse platelet and FFP
💡 Click to Reveal Answer & Nelson Rationale
Option B (G6PD deficiency, supportive care and packed cell transfusion)
Rasburicase is a recombinant urate oxidase used in tumor lysis syndrome (TLS) to rapidly lower uric acid. However, it is contraindicated in G6PD deficiency, as its metabolism produces hydrogen peroxide, leading to oxidative hemolysis and methemoglobinemia.The child’s acute pallor, hematuria, anemia, and signs of congestive heart failure within 24 hours of rasburicase administration strongly indicate rasburicase-induced hemolytic crisis due to unrecognized G6PD deficiency.Management includes: Immediate discontinuation of rasburicase Supportive care (oxygen, hydration) Packed red blood cell transfusion as needed for severe anemia
A 7-year-old child is evaluated after a sibling is diagnosed with a hemoglobinopathy. The child is asymptomatic and has never required transfusion. CBC shows Hb 12.4 g/dL, MCV 82 fL, and normal reticulocyte count. Hemoglobin analysis shows HbA 66%, HbF 31%, and HbA2 3%. There is no hepatosplenomegaly. Which diagnosis best explains this profile?
---
- (A) β-thalassemia trait
- (B) δβ-thalassemia trait
- (C) Hereditary persistence of fetal hemoglobin
- (D) Sickle cell disease with high HbF
💡 Click to Reveal Answer & Nelson Rationale
Option C (Hereditary persistence of fetal hemoglobin)
The key finding is markedly elevated HbF around 30% with normal hemoglobin, normal MCV, normal reticulocyte count, and no clinical disease. This pattern is most consistent with hereditary persistence of fetal hemoglobin. HPFH is a benign condition caused by heterozygous deletions or nucleotide substitutions in regulatory regions of the β-globin locus controlling HBG1 and HBG2, resulting in persistent pancellular HbF expression. Unlike β-thalassemia or sickle cell disease, isolated HPFH does not produce anemia or significant clinical manifestations.
A 5-year-old child presents with pallor after a recent viral illness. CBC shows Hb 6.8 g/dL, MCV 84 fL, normal leukocyte and platelet counts, and a very low reticulocyte count. There is no jaundice, splenomegaly, or bleeding history. Which of the following is the most likely cause of this anemia pattern?
---
- (A) Antibody-mediated hemolysis
- (B) Transient erythroblastopenia of childhood
- (C) Hereditary spherocytosis
- (D) Glucose-6-phosphate dehydrogenase deficiency
💡 Click to Reveal Answer & Nelson Rationale
Option B (Transient erythroblastopenia of childhood)
This child has normocytic anemia with an inadequate reticulocyte response, which points toward reduced red cell production rather than hemolysis or blood loss. Transient erythroblastopenia of childhood typically presents in young children after a viral illness with isolated normocytic anemia and marked reticulocytopenia, while other cell lines are preserved. The absence of jaundice, splenomegaly, and a high reticulocyte count makes hemolytic causes less likely.
![[d9d1bcf5_1786087879169_1786087880.png]]
A 4-year-old child with Diamond-Blackfan anemia is being considered for nontransplant therapy because of poor steroid tolerance and intermittent transfusion needs. A trial drug is discussed that has shown erythroid response in a minority of patients and improvement in weight and linear growth velocity in some children. Which drug is being described?
---
- (A) L-leucine
- (B) Cyclosporine
- (C) Eltrombopag
- (D) Hydroxyurea
💡 Click to Reveal Answer & Nelson Rationale
Option A (L-leucine)
In Diamond-Blackfan anemia, L-leucine has been evaluated as an oral therapy in children 2 years of age and older. In a phase I/II trial, it produced erythroid response in a minority of patients and was also associated with improved weight and linear growth velocity in some children. This makes it a distinctive therapy-related point in DBA, separate from corticosteroids, chronic transfusion therapy, chelation, and hematopoietic stem cell transplantation.
A 5-month-old infant has severe macrocytic anemia with reticulocytopenia. Bone marrow shows normal cellularity with marked paucity of erythroid precursors. A diagnosis of Diamond-Blackfan anemia is suspected. All of the following thumb/radial anomalies may be seen in this condition, except
---
- (A) Triphalangeal thumb
- (B) Duplex or bifid thumb
- (C) Absent radial artery
- (D) Absent radius
💡 Click to Reveal Answer & Nelson Rationale
Option D (Absent radius)
Diamond-Blackfan anemia may be associated with congenital thumb/radial-region abnormalities such as triphalangeal thumb, duplex or bifid thumb, hypoplastic thumb, flat thenar eminence, and absent radial artery. The clinical setting of early-onset macrocytic anemia, reticulocytopenia, and erythroid precursor paucity supports DBA. Absent radius is a close mimic because it is also a radial-side limb anomaly, but it is not the classical thumb anomaly listed for DBA and should suggest other radial ray disorders.
**Table: **Range of Congenital Anomalies Observed in Diamond-Blackfan Anemia
![[dc88036b_medium_table__6__1786211479.png]]
A 10-year-old child with end-stage renal disease is receiving erythropoiesis-stimulating agent therapy for anemia. After an initial response, he develops worsening severe anemia with marked reticulocytopenia despite adequate iron stores. What is the most appropriate next step?
---
- (A) Increase ESA dose and continue iron therapy
- (B) Change ESA therapy and continue iron therapy
- (C) Stop ESA therapy and consider immunomodulatory therapy
- (D) Continue ESA therapy with higher hemoglobin target
💡 Click to Reveal Answer & Nelson Rationale
Option C (Stop ESA therapy and consider immunomodulatory therapy)
This child has worsening anemia with marked reticulocytopenia after prior exposure to erythropoiesis-stimulating agents, despite adequate iron stores. This suggests anti-EPO antibody-mediated pure red cell aplasia, a rare complication of ESA therapy. In this situation, ESA therapy should be stopped, because continued exposure may perpetuate the antibody response. Immunomodulatory therapy may be required to suppress anti-EPO antibody production.
A 9-year-old child presents with chronic anemia, intermittent jaundice, and mild splenomegaly. He was previously suspected to have hereditary spherocytosis. CBC shows Hb 9 g/dL, normocytic anemia, and an inappropriately low reticulocyte count. Bone marrow is hypercellular with erythroid hyperplasia and shows 10-35% binucleated or multinucleated erythroblasts with nuclei of equal size. SDS-PAGE of red cell membrane proteins shows faster migration of hypoglycosylated band 3. Which diagnosis best explains this presentation?
---
- (A) Congenital dyserythropoietic anemia type I
- (B) Congenital dyserythropoietic anemia type II
- (C) Congenital dyserythropoietic anemia type III
- (D) Hereditary spherocytosis
💡 Click to Reveal Answer & Nelson Rationale
Option B (Congenital dyserythropoietic anemia type II)
The clinical picture is most consistent with congenital dyserythropoietic anemia type II, the most common CDA. It is an autosomal recessive disorder caused by biallelic pathogenic variants in SEC23B, which encodes a component of the COPII complex involved in endoplasmic reticulum vesicle trafficking. CDA II may mimic hereditary spherocytosis because both can present with anemia, jaundice, splenomegaly, or hepatomegaly. The key differentiators are ineffective erythropoiesis with an inappropriately low reticulocyte count, characteristic binucleated/multinucleated erythroblasts with equal-sized nuclei, and hypoglycosylated band 3 with faster migration on SDS-PAGE.
A 6-year-old boy presents with recurrent mucosal bleeding and chronic anemia. CBC shows macrocytic anemia with severe thrombocytopenia. Peripheral smear shows large, poorly granulated platelets. Bone marrow shows dyserythropoiesis with reduced abnormal megakaryocytes. Which gene is most likely involved?
---
- (A) KLF1
- (B) GATA1
- (C) SEC23B
- (D) CDAN1
💡 Click to Reveal Answer & Nelson Rationale
Option B (GATA1)
This child has features of X-linked thrombocytopenia with or without dyserythropoietic anemia, a transcription factor–related congenital dyserythropoietic anemia caused by pathogenic variants in GATA1. GATA1 is important for development and maintenance of both red cell and platelet lineages. The key clues are anemia with macrothrombocytopenia, poorly granulated platelets, bleeding manifestations, dyserythropoiesis, and abnormal reduced megakaryocytes in marrow.
A 9-year-old child is found to have anemia with increased MCV. Peripheral smear shows macrocytes but no hypersegmented neutrophils. Reticulocyte count is low. Bone marrow does not show megaloblastic maturation. Which of the following etiologies best fits this pattern?
---
- (A) Thiamine-responsive anemia
- (B) Hereditary orotic aciduria
- (C) Chronic liver disease
- (D) Methotrexate therapy
💡 Click to Reveal Answer & Nelson Rationale
Option C (Chronic liver disease)
This child has nonmegaloblastic macrocytosis. Macrocytosis may occur from megaloblastic or nonmegaloblastic causes. Hereditary orotic aciduria and methotrexate therapy are megaloblastic causes because they interfere with DNA synthesis and are usually associated with hypersegmented neutrophils and megaloblastic marrow changes. Chronic liver disease can cause macrocytosis without hypersegmented neutrophils and without megaloblastic maturation.
![[83fbabfa_large_1786264088.png]]
A 4-month-old infant presents with chronic diarrhea, recurrent infections, seizures, and developmental delay. CBC shows megaloblastic anemia. Serum and CSF folate levels are very low, with loss of the normal CSF-to-serum folate ratio. Which gene is most likely involved?
---
- (A) SLC46A1
- (B) MTHFR
- (C) DHFR
- (D) MTRR
💡 Click to Reveal Answer & Nelson Rationale
Option A (SLC46A1)
This infant has hereditary folate malabsorption, an autosomal recessive disorder caused by loss-of-function variants in SLC46A1, which encodes the proton-coupled folate transporter. The condition presents at 2-6 months of age with megaloblastic anemia, diarrhea, infections, and neurologic manifestations such as seizures, developmental delay, and intellectual disability. Folate transport is impaired both in the intestine and across the choroid plexus, causing very low serum and CSF folate levels with loss of the normal CSF-to-serum folate gradient.
A 3-year-old child presents with pallor, glossitis, irritability, and developmental delay. CBC shows macrocytic anemia with hypersegmented neutrophils and low serum vitamin B12. Gastric acid secretion is normal. Urine examination repeatedly shows proteinuria, which persists even after parenteral vitamin B12 corrects the anemia. What is the most likely diagnosis?
---
- (A) Hereditary intrinsic factor deficiency
- (B) Imerslund-Gräsbeck syndrome
- (C) Juvenile pernicious anemia
- (D) Hereditary folate malabsorption
💡 Click to Reveal Answer & Nelson Rationale
Option B (Imerslund-Gräsbeck syndrome)
The combination of megaloblastic anemia due to vitamin B12 deficiency with persistent proteinuria is the key clue to Imerslund-Gräsbeck syndrome. It is a rare autosomal recessive disorder caused by defects in CUBN or AMN, which encode components of the cubam receptor required for ileal absorption of the intrinsic factor–cobalamin complex. CUBN also participates in renal tubular protein reabsorption, explaining why proteinuria occurs and does not improve with vitamin B12 therapy.
A 9-month-old infant has failure to thrive and developmental delay. CBC shows severe megaloblastic anemia with normal leukocyte and platelet counts. Serum vitamin B12 and folate levels are normal. The anemia does not improve after vitamin B12 or folate therapy. Which treatment is most appropriate?
---
- (A) Thiamine
- (B) Copper
- (C) Folinic acid
- (D) Uridine
💡 Click to Reveal Answer & Nelson Rationale
Option D (Uridine)
This scenario suggests hereditary orotic aciduria, an autosomal recessive disorder of de novo pyrimidine synthesis. It usually presents in infancy with growth failure, developmental delay, severe megaloblastic anemia, normal vitamin B12 and folate levels, and failure to respond to vitamin B12 or folate therapy. The anemia responds promptly to uridine, which bypasses the defective pathway and restores pyrimidine nucleotide synthesis.
A 10-year-old child from a low-resource setting presents with fatigue, pallor, poor appetite, and chronic intermittent abdominal discomfort. CBC shows microcytic hypochromic anemia with low ferritin. There is no history of excessive milk intake or overt gastrointestinal bleeding. Stool examination is planned because parasitic infection is suspected to be contributing to iron deficiency. Which organism is an important contributor to iron-deficiency anemia in this setting?
---
- (A) Trichuris trichiura
- (B) Enterobius vermicularis
- (C) Giardia lamblia
- (D) Entamoeba histolytica
💡 Click to Reveal Answer & Nelson Rationale
Option A (Trichuris trichiura)
In developing countries, parasitic infections can contribute significantly to iron-deficiency anemia. Important organisms include hookworm, Trichuris trichiura, and Plasmodium. Trichuris trichiura can contribute to chronic intestinal blood loss and iron deficiency, especially in children living in settings with poor sanitation. The microcytic hypochromic anemia with low ferritin supports iron deficiency.
A 6-year-old child is evaluated for suspected hemolytic anemia. Which of the following is not a laboratory feature supportive of hemolysis?
---
- (A) Increased serum LDH
- (B) Increased urinary urobilinogen
- (C) Positive urine dipstick for blood with no RBCs on microscopy
- (D) Positive urine dipstick for blood with RBCs on microscopy
💡 Click to Reveal Answer & Nelson Rationale
Option D (Positive urine dipstick for blood with RBCs on microscopy)
Laboratory features supporting hemolysis include increased reticulocyte count, increased RDW, abnormal RBC morphology, increased indirect bilirubin, decreased serum haptoglobin, increased urinary urobilinogen, hemoglobinuria, and increased LDH. A positive urine dipstick for blood with no RBCs on microscopy suggests hemoglobinuria, which supports intravascular hemolysis. In contrast, a positive dipstick with RBCs present indicates true hematuria rather than hemoglobinuria and is not a laboratory criterion for hemolytic anemia.
![[feee65ba_small_1786264359.png]]
A 5-year-old child presents with recurrent jaundice and splenomegaly. CBC shows hemolytic anemia with reticulocytosis. Peripheral smear shows small hyperchromic red cells lacking central pallor. Which CBC-based screening combination has been suggested for hereditary spherocytosis?
---
- (A) MCHC >35.4 g/dL with RDW <14%
- (B) MCHC <32 g/dL with RDW >18%
- (C) MCV >100 fL with RDW <14%
- (D) MCV <70 fL with MCHC <30 g/dL
💡 Click to Reveal Answer & Nelson Rationale
Option A (MCHC >35.4 g/dL with RDW <14%)
Hereditary spherocytosis typically shows hemolytic anemia with reticulocytosis, indirect hyperbilirubinemia, splenomegaly, and spherocytes on peripheral smear. The MCV may be low-normal or slightly decreased, while the MCHC is usually increased because spherocytes are dehydrated and hyperchromic. A screening combination of MCHC >35.4 g/dL with RDW <14% has been suggested for hereditary spherocytosis.
A 5-year-old child with hereditary spherocytosis has severe hemolytic anemia requiring frequent transfusions and poor growth. Splenectomy is being discussed. Which of the following is the most appropriate recommendation?
---
- (A) Total splenectomy should be done before 5 years of age
- (B) Splenectomy is generally avoided in severe HS because it worsens hemolysis
- (C) Splenectomy should be delayed until after 6 years of age, if possible
- (D) Splenectomy is routinely recommended for all HS cases with reticulocytosis
💡 Click to Reveal Answer & Nelson Rationale
Option C (Splenectomy should be delayed until after 6 years of age, if possible)
Splenectomy is recommended for severe hereditary spherocytosis and should be strongly considered in moderate HS if there are frequent hypoplastic or aplastic crises, poor growth, or cardiomegaly. However, when splenectomy is indicated, it should preferably be delayed until after 6 years of age to reduce the heightened risk of postsplenectomy sepsis in younger children. Partial splenectomy may be considered in selected young children with severe disease requiring frequent transfusions.
A child is suspected to have sitosterolemia. All of the following are recognized clinical or hematologic features of this disorder, except
---
- (A) Early-onset xanthomatosis
- (B) Premature coronary artery disease
- (C) Marked hypercholesterolemia in all patients
- (D) Macrothrombocytopenia
💡 Click to Reveal Answer & Nelson Rationale
Option C (Marked hypercholesterolemia in all patients)
Sitosterolemia, also known as phytosterolemia, is caused by abnormal absorption and reduced elimination of plant sterols due to ABCG5 or ABCG8 variants. Clinical features include early-onset xanthomatosis, short stature, and premature coronary artery disease. Hematologic manifestations include macrothrombocytopenia and stomatocytic hemolytic anemia. Plasma cholesterol may be normal or abnormal, so marked hypercholesterolemia in all patients is not a consistent feature. Treatment involves dietary restriction of cholesterol and plant sterols and prescription of ezetimibe, a sterol absorption inhibitor, and cholestyramine and other related bile acid sequestering agents.
A child with aplastic anemia is found on high-resolution flow cytometry to have a very small population of GPI-anchor protein–deficient polymorphonuclear leukocytes. There is no clinical or biochemical evidence of intravascular hemolysis. Which category best describes this condition?
---
- (A) Classic PNH with small clone size
- (B) Bone marrow failure–associated PNH clone without hemolysis
- (C) Clinical PNH with marrow failure requiring complement blockade
- (D) Classic hemolytic PNH with absent hemoglobinuria
💡 Click to Reveal Answer & Nelson Rationale
Option B (Bone marrow failure–associated PNH clone without hemolysis)
This pattern corresponds to subclinical PNH. It is seen in the setting of a concomitant bone marrow failure syndrome, such as aplastic anemia, where high-resolution flow cytometry detects a very small GPI-anchor protein–deficient clone. There is no clinical or biochemical evidence of intravascular hemolysis, and eculizumab is not beneficial because the dominant problem is marrow failure rather than complement-mediated hemolysis.
![[c0dc592f_medium_1786264639.png]]
A 12-year-old child with aplastic anemia is found to have a small PNH clone on flow cytometry. Reticulocyte count is low, LDH is not significantly elevated, and there is no hemoglobinuria. According to the management approach for PNH, what is the most appropriate focus of treatment?
---
- (A) Start eculizumab immediately
- (B) Treat the underlying bone marrow failure syndrome
- (C) Proceed directly to splenectomy
- (D) Begin long-term anticoagulation as primary therapy
💡 Click to Reveal Answer & Nelson Rationale
Option B (Treat the underlying bone marrow failure syndrome)
This child has PNH in the setting of bone marrow failure without significant intravascular hemolysis. In such cases, management should focus on the underlying bone marrow failure syndrome, rather than PNH-directed complement blockade. Eculizumab is mainly useful in classic PNH with clinically significant hemolysis, raised LDH, and large GPI-deficient clones. Subclinical PNH or PNH associated predominantly with marrow failure usually does not benefit from eculizumab unless the clone is large and hemolysis becomes clinically significant.
![[8eb11309_1786089849931_1786089853.png]]
A 12-year-old child is being evaluated for possible paroxysmal nocturnal hemoglobinuria. In which of the following situations is PNH testing indicated in all patients unless a clear alternate explanation exists?
---
- (A) Cytopenia with a diagnostic marrow examination
- (B) Low-risk myelodysplastic syndrome without hypoplasia
- (C) Thrombosis provoked by central venous catheterization
- (D) Coombs-negative hemolysis with elevated LDH
💡 Click to Reveal Answer & Nelson Rationale
Option D (Coombs-negative hemolysis with elevated LDH)
PNH testing is indicated in patients with Coombs-negative hemolysis, especially when there is biochemical evidence of hemolysis such as elevated LDH, indirect hyperbilirubinemia, reduced haptoglobin, and a negative direct antiglobulin test. Flow cytometry is the diagnostic test of choice because it detects deficiency of GPI-anchored proteins such as CD55 and CD59 on blood cells.
A 14-year-old boy with sickle cell anemia presents at 6 AM with a painful penile erection lasting 5 hours. He has had several brief self-resolving episodes over the past month. Which is the most appropriate acute management?
---
- (A) Exchange transfusion as initial therapy
- (B) IV hydration, opioids, and observation
- (C) Oral pseudoephedrine with warm shower
- (D) Corporal aspiration with dilute epinephrine irrigation
💡 Click to Reveal Answer & Nelson Rationale
Option D (Corporal aspiration with dilute epinephrine irrigation)
This is prolonged priapism in sickle cell disease because the painful erection has lasted more than 4 hours. Priapism in sickle cell disease is a low-flow state caused by venous stasis and RBC sickling within the corpora cavernosa. A prolonged episode requires urgent urologic management with aspiration of blood from the corpora cavernosa followed by irrigation with dilute epinephrine to achieve detumescence.
A 12-year-old child with sickle cell disease has recurrent vaso-occlusive pain episodes despite standard supportive care. A disease-modifying drug is considered that is given as a monthly intravenous infusion and reduces acute pain by inhibiting P-selectin–mediated cell adhesion. Which drug is being described?
---
- (A) L-glutamine
- (B) Crizanlizumab
- (C) Voxelotor
- (D) Hydroxyurea
💡 Click to Reveal Answer & Nelson Rationale
Option B (Crizanlizumab)
Crizanlizumab is a humanized P-selectin inhibitor administered as a monthly intravenous infusion. It reduces acute pain episodes in sickle cell disease by interfering with adhesion between blood cells and endothelium, an important mechanism in vaso-occlusion. It is indicated for reducing acute pain in adults and children aged 16 years and older.
A 14-year-old child with sickle cell disease has recurrent vaso-occlusive crises despite standard therapy. He is planned for an approved autologous hematopoietic stem cell gene therapy after myeloablative conditioning. Which of the following best describes Casgevy/exa-cel?
---
- (A) Lentiviral addition of βA-T87Q globin gene
- (B) Monthly inhibition of P-selectin–mediated adhesion
- (C) Direct inhibition of sickle hemoglobin polymerization
- (D) CRISPR/Cas9 disruption of BCL11A in red cell precursors
💡 Click to Reveal Answer & Nelson Rationale
Option D (CRISPR/Cas9 disruption of BCL11A in red cell precursors)
Casgevy, also called exagamglogene autotemcel or exa-cel, is an ex vivo autologous hematopoietic stem cell gene therapy approved for patients aged 12 years and older with recurrent vaso-occlusive crises. It uses CRISPR/Cas9 editing to disrupt BCL11A in red cell precursors. Since BCL11A suppresses fetal hemoglobin expression, its disruption increases HbF production, which reduces sickling and vaso-occlusive crises.
A 16-year-old boy is found to have sickle cell trait during screening before joining a competitive football program. He is asymptomatic and has no history of exertional collapse. The family asks whether he should be restricted from sports because of reports of sudden death during intense exercise. Which recommendation is most appropriate?
---
- (A) Exclude from competitive sports
- (B) Allow participation with hydration and rest
- (C) Restrict unless prophylactic transfusion is given
- (D) Clear only after routine neurology and cardiology evaluation
💡 Click to Reveal Answer & Nelson Rationale
Option B (Allow participation with hydration and rest)
Sickle cell trait alone is not an indication to restrict or exclude a child from competitive sports. Children and adolescents with sickle cell trait may participate in physical conditioning and athletic activities, provided sensible precautions are followed. These include adequate oral hydration, frequent rest breaks, avoidance of heat exhaustion, and careful monitoring during intense exercise, especially in hot and humid conditions. Reports of sudden death during extreme exertion are thought to involve additional genetic or environmental factors rather than sickle cell trait itself, and no direct causal pathway has been established. Therefore, the appropriate recommendation is participation with hydration, rest, and prudent surveillance rather than exclusion.
A child of Asian-Indian ancestry is found to have a rare hemoglobin variant. The heterozygous state is clinically silent, but when inherited with HbS it can produce a sickle cell disease phenotype. Which hemoglobin variant is being described?
---
- (A) Hemoglobin C
- (B) Hemoglobin E
- (C) Hemoglobin O-Arab
- (D) Hemoglobin D-Punjab
💡 Click to Reveal Answer & Nelson Rationale
Option D (Hemoglobin D-Punjab)
Hemoglobin D-Punjab, also called HbD-Los Angeles, is a rare hemoglobin variant seen in some Western Indians and in people of Asian-Indian ancestry. The heterozygous state, HbAD, is clinically silent. However, when HbD-Punjab is inherited with HbS, it can produce symptoms of sickle cell disease. Homozygous HbDD disease usually causes mild to moderate anemia with splenomegaly.
A 12-year-old child with transfusion-dependent thalassemia is started on an oral iron chelator. Six weeks later, he develops high fever and severe sore throat. CBC shows marked neutropenia. Which iron chelator is most likely responsible?
---
- (A) Deferoxamine
- (B) Deferasirox
- (C) Deferiprone
- (D) Hydroxyurea
💡 Click to Reveal Answer & Nelson Rationale
Option C (Deferiprone)
Deferiprone is an oral iron chelator used in transfusional iron overload, particularly when current chelation therapy is inadequate or contraindicated. A key adverse effect of deferiprone is neutropenia or agranulocytosis, which may present with fever, sore throat, and severe neutropenia. This adverse effect makes regular blood count monitoring important during therapy.
A patient with transfusion-dependent β-thalassemia is started on a subcutaneous drug given once every 3 weeks to reduce transfusion burden. The drug acts by improving erythroid maturation rather than by chelating iron or increasing HbF. Which adverse effect is most likely associated with this therapy?
---
- (A) Agranulocytosis
- (B) Proximal tubular dysfunction
- (C) Bone pain
- (D) Pulmonary toxicity
💡 Click to Reveal Answer & Nelson Rationale
Option C (Bone pain)
The drug described is luspatercept, which is given subcutaneously every 3 weeks and improves erythroid maturation by binding TGFβ family ligands involved in ineffective erythropoiesis. It can reduce transfusion requirements in transfusion-dependent β-thalassemia. Important adverse effects include bone pain, arthralgia, dizziness, hypertension, and hyperuricemia.
A 6-year-old child with transfusion-dependent β-thalassemia is being considered for a one-time gene-based therapy. The approach involves harvesting autologous CD34+ cells and transducing them ex vivo with a replication-incompetent lentiviral vector carrying a modified β-globin gene. Which therapy is being described?
---
- (A) Exagamglogene autotemcel
- (B) Betibeglogene autotemcel
- (C) Luspatercept
- (D) Lovotibeglogene autotemcel
💡 Click to Reveal Answer & Nelson Rationale
Option B (Betibeglogene autotemcel)
Betibeglogene autotemcel is an FDA-approved one-time gene addition therapy for adults and children ≥4 years with transfusion-dependent β-thalassemia. It uses harvested autologous CD34+ hematopoietic stem cells that are transduced with a replication-incompetent lentiviral vector containing a modified functional β-globin gene. This restores β-globin production and can lead to transfusion independence in a high proportion of treated patients.
A 4-year-old child has chronic nonspherocytic hemolytic anemia with jaundice and splenomegaly. Peripheral smear shows polychromatophilia with mild macrocytosis and occasional spiculated pyknocytes. Hemoglobin electrophoresis is normal. Reticulocyte count is high. Which investigation is most appropriate for initial confirmation?
---
- (A) Osmotic fragility testing
- (B) EMA binding by flow cytometry
- (C) Red cell pyruvate kinase activity assay
- (D) Hemoglobin H inclusion test
💡 Click to Reveal Answer & Nelson Rationale
Option C (Red cell pyruvate kinase activity assay)
This scenario suggests pyruvate kinase deficiency, an inherited red cell enzyme defect causing chronic nonspherocytic hemolytic anemia. Polychromatophilia and mild macrocytosis reflect the increased reticulocyte count. Spherocytes are uncommon, and hemoglobin studies are normal. Diagnosis relies on demonstration of markedly reduced RBC pyruvate kinase activity or a high Km variant for phosphoenolpyruvate. Initial biochemical testing is recommended because molecular results may be difficult to interpret due to genotype-phenotype variability.
A 9-year-old child develops acute hemolytic anemia after starting medication. DAT is positive, and drug-induced immune hemolytic anemia is suspected. Which of the following drugs is classically associated with true autoantibody induction rather than hapten-mediated hemolysis?
---
- (A) Penicillin
- (B) Cefotetan
- (C) Methyldopa
- (D) Quinidine
💡 Click to Reveal Answer & Nelson Rationale
Option C (Methyldopa)
Drug-induced immune hemolytic anemia can occur through different mechanisms. Methyldopa is classically associated with true autoantibody induction, producing warm autoantibodies against RBCs. In contrast, penicillin is a classic example of hapten/drug adsorption, while quinidine and quinine are examples of ternary immune-complex mechanisms.
![[fd726341_medium__1__1786264942.png]]
A 7-year-old child with warm autoimmune hemolytic anemia has persistent hemolysis despite glucocorticoids and IVIG. A second-line monoclonal antibody is planned to reduce autoantibody production by targeting B lymphocytes. Which drug is most appropriate?
---
- (A) Rituximab
- (B) Daratumumab
- (C) Alemtuzumab
- (D) Bortezomib
💡 Click to Reveal Answer & Nelson Rationale
Option A (Rituximab)
In refractory or chronic warm autoimmune hemolytic anemia, rituximab is a useful second-line therapy. It is a monoclonal antibody directed against B lymphocytes, which are the source of autoantibody production. By reducing B-cell–mediated antibody production, rituximab can help control ongoing immune hemolysis when conventional therapy is inadequate. In refractory disease, several immunomodulating agents have been used in small case series or reports including azathioprine, 6- mercaptopurine, cyclosporine, mycophenolate mofetil, tacrolimus, sirolimus, and monoclonal antibodies (e.g., obinutuzumab, daratumumab, alemtuzumab, bortezomib).
A 10-year-old child develops hemolytic anemia after a febrile respiratory illness. The blood sample shows visible red cell clumping when kept at room temperature, and the automated CBC reports a falsely high MCV. DAT is positive for C3 but negative for IgG. The antibody reacts poorly with cord blood red cells. Which infection is most likely associated with this episode?
---
- (A) Epstein-Barr virus
- (B) Parvovirus B19
- (C) Cytomegalovirus
- (D) Mycoplasma pneumoniae
💡 Click to Reveal Answer & Nelson Rationale
Option D (Mycoplasma pneumoniae)
This is cold agglutinin disease, caused by cold-reactive IgM antibodies that activate complement. DAT usually detects C3 only, because IgM is removed during washing. The important clue is that the antibody reacts poorly with cord blood RBCs. Cord RBCs predominantly express i antigen and have low levels of I antigen, so poor reactivity with cord cells suggests anti-I antibody. Anti-I cold agglutinins are classically associated with Mycoplasma pneumoniae infection.
A 4-year-old child develops acute kidney injury, thrombocytopenia, and microangiopathic hemolytic anemia after pneumococcal sepsis. Peripheral smear shows schistocytes. Pneumococcal-induced HUS with T-antigen activation is suspected. Which intervention should be avoided because it can worsen hemolysis?
---
- (A) Plasma infusion
- (B) Red cell transfusion
- (C) Platelet transfusion with plasma support
- (D) Antibiotic therapy
💡 Click to Reveal Answer & Nelson Rationale
Option A (Plasma infusion)
Pneumococcal-induced HUS occurs when pneumococcal neuraminidase damages RBC and renal cell membranes, exposing the T antigen. Plasma naturally contains antibodies against the T antigen. Therefore, giving plasma infusion can intensify antibody-mediated RBC destruction and worsen hemolysis, potentially causing life-threatening anemia. This is an important difference from TTP, where plasma exchange or plasma replacement has a central role.
A 13-year-old child is evaluated for persistent erythrocytosis. Oxygen saturation is normal. Serum erythropoietin level is low. Bone marrow biopsy shows hypercellularity with trilineage growth, including prominent erythroid, granulocytic, and megakaryocytic proliferation with pleomorphic mature megakaryocytes. Which additional finding would most strongly support the diagnosis?
---
- (A) Elevated carboxyhemoglobin level
- (B) High oxygen-affinity hemoglobin variant
- (C) JAK2 mutation
- (D) Elevated serum erythropoietin level
💡 Click to Reveal Answer & Nelson Rationale
Option C (JAK2 mutation)
This scenario suggests polycythemia vera, a clonal primary polycythemia. The key clues are persistent erythrocytosis, low serum erythropoietin, and marrow panmyelosis with trilineage proliferation. WHO diagnostic criteria include increased hemoglobin/hematocrit or red cell mass, characteristic bone marrow morphology, and presence of a JAK2 or JAK2 exon 12 mutation. A subnormal serum erythropoietin level is a minor criterion.
![[775cb187_medium__2__1786265243.png]]
A 13-year-old child is diagnosed with polycythemia vera and has symptoms of hyperviscosity. There is no history of thrombosis, progressive splenomegaly, marked leukocytosis, or thrombocytosis. Which is the most appropriate initial treatment?
---
- (A) Phlebotomy with low-dose aspirin
- (B) Ruxolitinib as first-line therapy
- (C) Hydroxyurea with iron restriction
- (D) Busulfan with platelet transfusion
💡 Click to Reveal Answer & Nelson Rationale
Option A (Phlebotomy with low-dose aspirin)
In polycythemia vera, the initial treatment is phlebotomy and low-dose aspirin. Phlebotomy reduces hyperviscosity symptoms by lowering red cell mass, while low-dose aspirin decreases thrombotic risk. In children, data are limited because the disease is rare, and often only phlebotomy is required. Iron supplementation may be needed to prevent iron-deficient microcytosis or thrombocytosis, which can worsen viscosity-related problems.
A 16-year-old with Fanconi anemia is on long-term follow-up for marrow failure and malignancy risk. Which of the following malignancies is classically associated with the highest relative risk in this condition?
---
- (A) Hepatocellular carcinoma after viral hepatitis
- (B) Upper esophageal carcinoma
- (C) Papillary thyroid carcinoma
- (D) Medulloblastoma
💡 Click to Reveal Answer & Nelson Rationale
Option B (Upper esophageal carcinoma)
Fanconi anemia is associated with a markedly increased risk of malignancy, especially squamous cell carcinomas of the head and neck, upper esophagus, vulva, anus, cervix, and lower esophagus. Among these, carcinoma of the upper esophagus has an extremely high relative risk, around 2,000-fold above the general population. Solid tumors occur earlier than in the general population, with median onset of SCC around 33 years in Fanconi anemia.
A 12-year-old child has short stature, thumb anomaly, café-au-lait spots, and unexplained pancytopenia. Fanconi anemia is suspected. Peripheral blood lymphocyte chromosomal breakage study with DEB/MMC is negative, but clinical suspicion remains high. What is the most appropriate next step?
---
- (A) Exclude Fanconi anemia because DEB/MMC testing is negative
- (B) Confirm diagnosis with osmotic fragility testing
- (C) Repeat testing using cultured skin fibroblasts
- (D) Perform CT-based whole-body screening for anomalies
💡 Click to Reveal Answer & Nelson Rationale
Option B (Confirm diagnosis with osmotic fragility testing)
Fanconi anemia should be considered in children or young adults with unexplained cytopenias, especially when associated with characteristic congenital anomalies. The diagnosis is classically supported by increased chromosomal breakage after exposure to DNA cross-linking agents such as DEB or MMC. However, about 10–15% of suspected patients may have somatic mosaicism, causing peripheral blood lymphocytes to show less chromosomal fragility because some hematopoietic cells have undergone spontaneous correction. Therefore, if suspicion remains high despite negative lymphocyte testing, chromosomal breakage testing should be performed on cultured skin fibroblasts.
A 3-year-old child is evaluated for chronic neutropenia, poor growth, and recurrent infections. Stool studies suggest fat malabsorption, and pancreatic imaging shows fatty change. Skeletal survey is initially normal. Chromosomal breakage study with DEB/MMC is normal. Which of the following is the most appropriate diagnostic approach?
---
- (A) Exclude Shwachman-Diamond syndrome because metaphyseal dysplasia is absent
- (B) Diagnose Fanconi anemia because marrow dysfunction and growth failure are present
- (C) Perform genetic testing for SBDS, DNAJC21, and EFL1
- (D) Diagnose Pearson syndrome because pancreatic insufficiency is present
💡 Click to Reveal Answer & Nelson Rationale
Option C (Perform genetic testing for SBDS, DNAJC21, and EFL1)
This child has features suggestive of Shwachman-Diamond syndrome, including bone marrow dysfunction, exocrine pancreatic insufficiency, fat malabsorption, growth failure, and recurrent infections. Although the clinical diagnosis relies on evidence of two of the following—bone marrow dysfunction, exocrine pancreatic insufficiency, and metaphyseal dysplasia—metaphyseal dysplasia may be absent at diagnosis because it can develop with age. Up to 20% may lack clear pancreatic defects initially, and 20–60% may lack metaphyseal dysplasia at diagnosis. Therefore, suspected cases should undergo genetic testing for SBDS, DNAJC21, and EFL1, which is definitive in almost all cases.
A 3-year-old child has intrauterine growth restriction, developmental delay, progressive pancytopenia, abnormal nails, oral leukoplakia, and reticulated skin pigmentation. MRI brain shows cerebellar hypoplasia. Which diagnosis best explains this presentation?
---
- (A) Revesz syndrome
- (B) Hoyeraal-Hreidarsson syndrome
- (C) Coats plus syndrome
- (D) Fanconi anemia
💡 Click to Reveal Answer & Nelson Rationale
Option B (Hoyeraal-Hreidarsson syndrome)
This child has a severe variant of dyskeratosis congenita. Hoyeraal-Hreidarsson syndrome presents in early childhood with features of dyskeratosis congenita along with cerebellar hypoplasia, which is required to establish the diagnosis. Other associated features include developmental delay, intrauterine growth restriction, bone marrow failure, and sometimes severe immunodeficiency. It is genetically heterogeneous but is classically associated with X-linked recessive pathogenic variants in DKC1.
A neonate presents with severe thrombocytopenia and intracranial hemorrhage. Hemoglobin and leukocyte counts are initially normal. Bone marrow shows preserved cellularity with absent megakaryocytes. Genetic testing shows a nonsense pathogenic variant affecting the thrombopoietin receptor. Which clinical course is most likely?
---
- (A) Transient thrombocytopenia with spontaneous recovery in infancy
- (B) Isolated thrombocytopenia without marrow failure
- (C) Progression to pancytopenia and spontaneous recovery eventually
- (D) Progression to pancytopenia and aplastic anemia
💡 Click to Reveal Answer & Nelson Rationale
Option D (Progression to pancytopenia and aplastic anemia)
This neonate has congenital amegakaryocytic thrombocytopenia type I, caused by nonsense pathogenic variants in MPL, the gene encoding the thrombopoietin receptor. Nonsense variants cause complete loss of receptor function, resulting in severe persistent thrombocytopenia from early infancy due to absent megakaryocytes. Because thrombopoietin signaling also supports hematopoietic stem cell survival, these patients commonly progress from isolated thrombocytopenia to pancytopenia and aplastic anemia.
A 9-year-old child is diagnosed with severe acquired aplastic anemia. He has no HLA-matched family donor. Immunosuppressive therapy is planned. Which regimen is the major treatment option in this setting?
---
- (A) Horse ATG with cyclosporine
- (B) Cyclophosphamide with fludarabine
- (C) Alemtuzumab-based conditioning followed by HSCT
- (D) Matched-related allogeneic HSCT
💡 Click to Reveal Answer & Nelson Rationale
Option A (Horse ATG with cyclosporine)
In severe acquired aplastic anemia, an HLA-matched family donor HSCT offers excellent long-term survival, but only a minority of patients have such a donor. For children without an HLA-matched sibling/family donor, the major treatment is immunosuppression with horse antithymocyte globulin and cyclosporine, with response rates around 60–70%. The median time to response is approximately 6 months, and relapse may occur after stopping immunosuppression.
A 7-year-old child is evaluated for persistent pancytopenia. Bone marrow examination shows dysplastic hematopoiesis with 8% marrow blasts. Cytogenetic testing reveals monosomy 7. Which diagnosis is most appropriate?
---
- (A) Refractory cytopenia of childhood
- (B) Hypocellular aplastic anemia
- (C) MDS with excess blasts
- (D) AML evolving from MDS
💡 Click to Reveal Answer & Nelson Rationale
Option C (MDS with excess blasts)
This child has pediatric myelodysplastic syndrome with excess blasts. Refractory cytopenia of childhood is defined by peripheral blasts <2% and marrow blasts <5%. MDS with excess blasts is diagnosed when peripheral blasts are 2–19% and/or marrow blasts are 5–19%. Since this child has 8% marrow blasts, the correct diagnosis is MDS with excess blasts. Monosomy 7 is the most common clonal cytogenetic abnormality in pediatric MDS.
A preterm neonate requires repeated small-volume packed RBC transfusions of 15 mL/kg during NICU stay. The resident requests only “fresh” RBC units stored for <7 days because of concerns about potassium accumulation, loss of 2,3-DPG, and RBC storage injury. Which statement is most appropriate?
---
- (A) Fresh RBCs reduce NEC, ROP, BPD, IVH, and mortality
- (B) Stored RBCs up to 42 days are avoided in preterm neonates
- (C) Fresh RBCs are preferred because 2,3-DPG loss causes poor oxygen delivery
- (D) A reserved single RBC unit may be used for multiple aliquots during storage
💡 Click to Reveal Answer & Nelson Rationale
Option D (A reserved single RBC unit may be used for multiple aliquots during storage)
For small-volume transfusions commonly given to neonates, many centers reserve a single RBC unit for an infant and use multiple aliquots from that unit during its storage period, up to 42 days. Although stored RBCs have changes such as extracellular potassium accumulation, reduced 2,3-DPG, altered deformability, and nitric oxide quenching, these have not been shown to cause clinically significant problems in this setting. Trials comparing fresh RBCs with stored RBCs in preterm neonates have not shown benefit of fresh RBCs for mortality or major neonatal morbidities such as NEC, ROP, BPD, or IVH.
A 1.2-kg preterm neonate requires repeated platelet transfusions for severe thrombocytopenia. The blood bank has no CMV-seronegative platelet units immediately available, but leukoreduced CMV-untested platelets are available. Which is the most appropriate approach?
---
- (A) Delay transfusion until CMV-seronegative platelets are available
- (B) Give group O platelets repeatedly irrespective of recipient ABO group
- (C) Reduce platelet volume by centrifugation before each transfusion
- (D) Transfuse leukoreduced platelets without delaying therapy
💡 Click to Reveal Answer & Nelson Rationale
Option D (Transfuse leukoreduced platelets without delaying therapy)
In neonates and infants requiring repeated platelet transfusions, leukoreduced blood products are recommended to reduce HLA alloimmunization, platelet refractoriness, and transfusion-transmitted CMV risk. Although CMV-seronegative components may be preferred in some settings, platelet transfusion should not be delayed if CMV-negative units are unavailable. CMV-untested leukoreduced platelets are an acceptable low-risk alternative when transfusion is clinically needed.
A premature neonate requires a transfusion. The donor is the infant’s father, who is a partially HLA-matched blood relative. Which processing step is essential before transfusing this cellular blood product?
---
- (A) Leukoreduction alone
- (B) CMV seronegative selection only
- (C) Irradiation of the blood product
- (D) Washing of the blood product
💡 Click to Reveal Answer & Nelson Rationale
Option C (Irradiation of the blood product)
Directed donations from blood relatives must always be irradiated because of the risk of transfusion-associated graft-versus-host disease. This can occur when immunocompetent donor lymphocytes engraft in the recipient, especially when the donor is HLA-homozygous or haploidentical relative to the recipient. Irradiation prevents proliferation of transfused lymphocytes and is required for cellular blood products in high-risk settings.
A 20-kg child with severe hemophilia A presents with suspected intracranial hemorrhage. The target factor VIII activity is 100%. Using the standard emergency dosing formula, how much factor VIII concentrate should be given?
---
- (A) 500 IU
- (B) 1,000 IU
- (C) 1,500 IU
- (D) 2,600 IU
💡 Click to Reveal Answer & Nelson Rationale
Option B (1,000 IU)
For hemophilia A, factor VIII dose is calculated as: Factor VIII dose = desired % rise × weight × 0.5. Here, the desired rise is 100% and the child weighs 20 kg. So, 100 × 20 × 0.5 = 1,000 IU. For life-threatening or major hemorrhage, factor levels should be raised to approximately 100% activity.
A 6-year-old child with severe hemophilia A is started on prophylaxis to prevent recurrent joint bleeding. He is given a subcutaneous drug once monthly after initial weekly loading doses. At follow-up, his aPTT is markedly shortened. Which statement about this drug is correct?
---
- (A) It directly replaces deficient factor VIII during acute bleeds
- (B) It reduces antithrombin synthesis using small interfering RNA
- (C) It bridges activated factor IX and factor X to restore factor X activation
- (D) It decouples recombinant factor VIII from endogenous von Willebrand factor
💡 Click to Reveal Answer & Nelson Rationale
Option C (It bridges activated factor IX and factor X to restore factor X activation)
The drug described is emicizumab, a bispecific humanized monoclonal antibody approved for prophylaxis in hemophilia A. It mimics part of the function of activated factor VIII by bridging activated factor IX and factor X, thereby restoring factor X activation. It is given subcutaneously after loading doses and can be administered 1–4 times per month. Because it mimics activated factor VIII activity, it markedly shortens the aPTT. However, it is used for prophylaxis, not for treatment of acute bleeding.
A neonate presents with persistent umbilical stump bleeding followed by seizures. Neuroimaging shows intracranial hemorrhage. There is no thrombocytopenia, and fibrinogen level is normal. Coagulation profile shows prolongation of both PT and aPTT. Factor assay reveals activity <5% of normal. Which coagulation factor deficiency best explains this presentation?
---
- (A) Factor VII deficiency
- (B) Factor VIII deficiency
- (C) Factor X deficiency
- (D) Factor XIII deficiency
💡 Click to Reveal Answer & Nelson Rationale
Option C (Factor X deficiency)
This neonate most likely has severe factor X deficiency, a rare autosomal recessive bleeding disorder. Severe deficiency, usually <1–10% of normal activity, may present in neonates with umbilical bleeding and intracranial hemorrhage. Since factor X is part of the common coagulation pathway, deficiency leads to prolongation of both PT and aPTT. Diagnosis is confirmed by a factor X-specific assay. Treatment options include fresh frozen plasma, prothrombin complex concentrate, or plasma-derived factor X concentrate.
A 12-year-old boy has recurrent epistaxis and prolonged bleeding after minor procedures. His platelet count is normal. PT is normal, and aPTT is prolonged. Factor VIII activity is markedly reduced, but VWF antigen and VWF ristocetin cofactor activity are normal or only mildly decreased. VWF multimer distribution is normal. He is initially suspected to have mild hemophilia A, but VWF testing suggests a different diagnosis. Which type of von Willebrand disease is most likely?
---
- (A) Type 2A VWD
- (B) Type 2B VWD
- (C) Type 2M VWD
- (D) Type 2N VWD
💡 Click to Reveal Answer & Nelson Rationale
Option D (Type 2N VWD)
Type 2N von Willebrand disease is caused by defective binding of VWF to factor VIII. Because VWF normally protects factor VIII from clearance, impaired binding leads to disproportionately low factor VIII activity and may mimic mild hemophilia A. However, VWF antigen, VWF activity, and multimer distribution are usually normal or only mildly reduced, helping distinguish type 2N VWD from hemophilia A.
![[6c645ecd_small__1__1786265476.png]]
![[d37a8859_small__2__1786265633.png]]
A 6-year-old child with known von Willebrand disease presents with recurrent oral mucosal bleeding and epistaxis. The bleeding is mild to moderate, and he is otherwise stable. The physician wants to add an adjunctive therapy that can be used across all VWD types for mucosal bleeding. Which treatment is most appropriate?
---
- (A) Intranasal desmopressin, 1 spray in children <50 kg
- (B) VWF concentrate, 40–60 ristocetin cofactor units/kg IV
- (C) Tranexamic acid, 1,300 mg orally three times daily for 5 days
- (D) Recombinant VWF with additional recombinant factor VIII
💡 Click to Reveal Answer & Nelson Rationale
Option C (Tranexamic acid, 1,300 mg orally three times daily for 5 days)
For mucosal bleeding in von Willebrand disease, antifibrinolytics are useful across all VWD types because mucosal surfaces have high fibrinolytic activity. Tranexamic acid is given orally, commonly as 1,300 mg three times daily for 5 days, and is especially useful for epistaxis, oral bleeding, dental procedures, and menorrhagia.
![[13e5ea9c_medium__3__1786265893.png]]
A 14-year-old girl with von Willebrand disease is planned for surgery. Baseline testing shows reduced VWF activity, loss of high-molecular-weight multimers, and intermittent thrombocytopenia. Low-dose ristocetin-induced platelet aggregation is increased. Which treatment should be avoided or used with great caution?
---
- (A) Tranexamic acid
- (B) VWF-containing concentrate
- (C) Desmopressin
- (D) Platelet transfusion
💡 Click to Reveal Answer & Nelson Rationale
Option C (Desmopressin)
This patient has type 2B von Willebrand disease, caused by gain-of-function variants that increase VWF binding to platelet GPIb. This causes increased clearance of both VWF and platelets, leading to reduced VWF activity, loss of high-molecular-weight multimers, and sometimes thrombocytopenia. The key diagnostic clue is increased response to low-dose ristocetin. Desmopressin is relatively contraindicated because it may worsen VWF-platelet binding and accelerate clearance, potentially aggravating thrombocytopenia.
A 2-day-old neonate develops rapidly progressive purpuric skin lesions with areas of hemorrhagic necrosis. Laboratory evaluation suggests disseminated intravascular coagulation. There is concern for thrombosis of small dermal vessels due to a severe inherited thrombophilia. Which underlying defect is most likely?
---
- (A) Heterozygous factor V Leiden variant
- (B) Prothrombin G20210A variant
- (C) Heterozygous antithrombin deficiency
- (D) Homozygous protein C deficiency
💡 Click to Reveal Answer & Nelson Rationale
Option D (Homozygous protein C deficiency)
This neonate has purpura fulminans, which may occur in severe homozygous deficiency of protein C or protein S. It presents in the neonatal period with rapidly spreading purpuric lesions due to thrombosis of small dermal vessels, followed by bleeding into the skin. Infants may also develop DIC, cerebral thrombosis, ophthalmic thrombosis, and large-vessel thrombosis. An infant with unexplained purpuric skin lesions should receive empiric replacement with fresh frozen plasma while evaluation is ongoing.
A 5-year-old child with extensive iliofemoral thrombosis is receiving an antithrombotic agent by continuous IV infusion. During monitoring, the team is not following aPTT or INR, but instead checks fibrin degradation products and D-dimer to assess a “lytic state.” Which agent is most likely being used?
---
- (A) Unfractionated heparin
- (B) Low-molecular-weight heparin
- (C) Recombinant tissue plasminogen activator
- (D) Warfarin
💡 Click to Reveal Answer & Nelson Rationale
Option C (Recombinant tissue plasminogen activator)
The agent described is a recombinant tissue plasminogen activator. It is used for recent-onset life- or limb-threatening thrombosis and is given as a continuous IV infusion. Unlike unfractionated heparin, warfarin, or low-molecular-weight heparin, monitoring focuses on the presence of a lytic state, assessed using fibrin degradation products or D-dimer. Its major limitation is a higher risk of bleeding.
![[61156a6d_medium__4__1786266186.png]]
A 16-year-old adolescent with venous thromboembolism is being considered for an oral anticoagulant. The clinician wants to avoid a drug with the highest renal elimination because the patient has chronic kidney disease. Among the following direct oral anticoagulants, which should be avoided preferentially on this basis?
---
- (A) Apixaban
- (B) Betrixaban
- (C) Dabigatran
- (D) Rivaroxaban
💡 Click to Reveal Answer & Nelson Rationale
Option C (Dabigatran)
Among the listed direct oral anticoagulants, dabigatran has the highest renal elimination, with more than 80% cleared renally. It is a direct thrombin inhibitor and has idarucizumab as a specific reversal agent. In contrast, apixaban, betrixaban, and rivaroxaban are factor Xa inhibitors and have lower renal elimination compared with dabigatran.
![[ba5bd149_medium__5__1786266401.png]]
A 13-year-old child develops a first episode of lower-limb venous thromboembolism after prolonged hospitalization and central venous catheter use. The catheter has now been removed, and there is no ongoing thrombosis risk factor. What is the recommended duration of therapeutic anticoagulation?
---
- (A) 3 months
- (B) 3–6 months
- (C) 6–12 months
- (D) 1–2 years
💡 Click to Reveal Answer & Nelson Rationale
Option A (3 months)
This is a first VTE episode with a provoked, reversible risk factor. Since the provoking factor was temporary and has resolved, therapeutic anticoagulation is recommended for 3 months. Longer treatment is used for unprovoked VTE, persistent risk factors, or recurrent thrombosis.
![[59fcabc7_small__3__1786266760.png]]
A 6-year-old child is evaluated for recurrent epistaxis, easy bruising, and prolonged oozing after dental extraction. Platelet count is persistently low. Peripheral smear shows enlarged platelets, but ristocetin-induced platelet aggregation is not absent. Low-dose ristocetin-induced platelet agglutination is not increased. There are no dysmorphic facial features or congenital cardiac defects. Over follow-up, the child develops progressive splenomegaly. Which diagnosis is most likely?
---
- (A) Bernard-Soulier syndrome
- (B) Platelet-type von Willebrand disease
- (C) Gray platelet syndrome
- (D) Paris-Trousseau/Jacobsen syndrome
💡 Click to Reveal Answer & Nelson Rationale
Option C (Gray platelet syndrome)
This is most consistent with gray platelet syndrome, an inherited platelet α-granule disorder. It can present with mucocutaneous bleeding, thrombocytopenia, enlarged platelets, and later progressive splenomegaly or marrow fibrosis. The stem excludes two close mimics: Bernard-Soulier syndrome, which has absent ristocetin-induced platelet aggregation, and platelet-type VWD, which has increased low-dose ristocetin-induced platelet agglutination. Absence of congenital cardiac, facial, or cognitive abnormalities makes Paris-Trousseau/Jacobsen syndrome less likely.
A 7-year-old child with immune thrombocytopenia is treated because of recurrent mucosal bleeding and a very low platelet count. The platelet count improves rapidly over the next 48 hours. Soon after therapy, the child develops severe headache, vomiting, and neck discomfort, but CSF culture remains sterile. Which treatment was most likely given?
---
- (A) IVIG
- (B) Rituximab
- (C) TPO receptor agonist
- (D) Corticosteroids
💡 Click to Reveal Answer & Nelson Rationale
Option A (IVIG)
The rapid platelet rise within 48 hours after treatment for ITP suggests IVIG. A characteristic adverse effect is headache and vomiting, sometimes due to IVIG-induced aseptic meningitis. This is a useful clinical clue when the drug name is not directly mentioned.
A 9-year-old child is evaluated for incidentally detected thrombocytopenia. He has mild mucocutaneous bleeding since early childhood. Peripheral smear shows very large platelets, and neutrophils show cytoplasmic inclusion bodies. His father has thrombocytopenia and early-onset sensorineural hearing loss. MYH9-related thrombocytopenia is suspected. All of the following syndromes are included under MYH9-related thrombocytopenias except
---
- (A) May-Hegglin anomaly
- (B) Epstein syndrome
- (C) Paris-Trousseau/Jacobsen syndrome
- (D) Fechtner syndrome
💡 Click to Reveal Answer & Nelson Rationale
Option C (Paris-Trousseau/Jacobsen syndrome)
MYH9-related thrombocytopenias are autosomal dominant macrothrombocytopenia syndromes caused by pathogenic variants in MYH9, encoding nonmuscle myosin-IIa heavy chain. They include May-Hegglin anomaly, Sebastian syndrome, Epstein syndrome, and Fechtner syndrome. The key clues are large platelets, mild usually nonprogressive thrombocytopenia, neutrophil inclusion bodies, and variable systemic features such as sensorineural deafness, renal disease, and eye disease.
**Why option C is close but incorrect:** Paris-Trousseau/Jacobsen syndrome also causes thrombocytopenia with large platelets, making it a close mimic. However, it is due to chromosome 11q23–24 deletion with hemizygous deletion of FLI1, and is associated with giant α-granules on TEM, immature megakaryocytes, and cognitive, cardiac, and facial abnormalities—not MYH9 variants.
A 4-year-old child with hereditary spherocytosis is being considered for elective splenectomy because of severe hemolysis. The family asks why the operation is being postponed if possible. Which reason best supports delaying splenectomy in this child?
---
- (A) Splenectomy is ineffective before 5 years of age
- (B) Postsplenectomy thrombocytosis is usually fatal in young children
- (C) Risk of overwhelming infection is higher in younger children
- (D) Pneumococcal vaccination is contraindicated before 5 years of age
💡 Click to Reveal Answer & Nelson Rationale
Option C (Risk of overwhelming infection is higher in younger children)
Elective splenectomy should be avoided unless clearly necessary and, when possible, postponed until the child is ≥5 years of age because young children are at higher risk of overwhelming postsplenectomy infection. The spleen is important for blood filtration and early antibody responses, especially against encapsulated organisms such as Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis.
A 5-year-old child has a localized, soft, transilluminant neck swelling. MRI suggests a macrocystic lymphatic malformation without diffuse or invasive disease. The lesion is symptomatic because of intermittent swelling and local discomfort. Which treatment is most appropriate?
---
- (A) Sirolimus as first-line therapy
- (B) Alpelisib after PIK3CA testing
- (C) Interventional radiology-guided sclerotherapy
- (D) Trametinib for MEK pathway inhibition
💡 Click to Reveal Answer & Nelson Rationale
Option C (Interventional radiology-guided sclerotherapy)
For a localized macrocystic lymphatic malformation, the most effective treatment is interventional radiology-guided administration of a sclerosing agent, such as OK432, ethanol, or bleomycin. The decision to treat depends on anatomic location, symptoms, and involvement of surrounding structures, and referral to a specialized vascular anomalies clinic is recommended.
A child is evaluated for congenital lower-limb swelling and recurrent cellulitis. Family history reveals similar swelling in multiple relatives. Genetic testing identifies a pathogenic variant in VEGFR3. Which diagnosis is most likely?
---
- (A) Meige disease
- (B) Milroy disease
- (C) Emberger syndrome
- (D) Hennekam lymphangiectasia-lymphedema syndrome
💡 Click to Reveal Answer & Nelson Rationale
Option B (Milroy disease)
Milroy disease is a form of primary congenital lymphedema associated with pathogenic variants in VEGFR3 and autosomal dominant inheritance. It usually presents early in life with lower-limb lymphedema. This distinguishes it from Meige disease, which is familial lymphedema without a known gene in the table.
A child with congenital lymphedema is being evaluated for an associated chromosomal aneuploidy. All of the following syndromes are associated with lymphedema except
---
- (A) Klinefelter syndrome
- (B) Trisomy 21
- (C) Trisomy 5
- (D) Trisomy 13
💡 Click to Reveal Answer & Nelson Rationale
Option C (Trisomy 5)
Chromosomal aneuploidies associated with lymphedema include Turner syndrome, Klinefelter syndrome, trisomy 21, trisomy 13, and trisomy 18. Trisomy 5 is not listed among the chromosomal aneuploidies associated with lymphedema.
A child with congenital lymphedema is being evaluated for an associated chromosomal aneuploidy. All of the following syndromes are associated with lymphedema except
---
- (A) Klinefelter syndrome
- (B) Trisomy 21
- (C) Trisomy 5
- (D) Trisomy 13
💡 Click to Reveal Answer & Nelson Rationale
Option C (Trisomy 5)
Chromosomal aneuploidies associated with lymphedema include Turner syndrome, Klinefelter syndrome, trisomy 21, trisomy 13, and trisomy 18. Trisomy 5 is not listed among the chromosomal aneuploidies associated with lymphedema.
A 9-year-old child has multifocal lymphatic vascular lesions involving soft tissue and bone. He develops recurrent chylous pleural effusions and protein-losing enteropathy. Imaging shows progressive cortical bone loss in one affected limb. Which complex lymphatic anomaly is most likely?
---
- (A) Generalized lymphatic anomaly
- (B) Gorham-Stout disease
- (C) Kaposiform lymphangiomatosis
- (D) Central conducting lymphatic anomaly
💡 Click to Reveal Answer & Nelson Rationale
Option B (Gorham-Stout disease)
Complex lymphatic anomalies are multifocal lymphatic vascular disorders that may involve soft tissue, bone, and central lymphatic channels. Shared features include bone involvement, chylous effusions, chylous ascites, and protein-losing enteropathy. The distinguishing clue in this case is progressive cortical bone loss, which is characteristic of Gorham-Stout disease.
A 6-year-old boy has lifelong easy bruising and frequent epistaxis. CBC shows hemoglobin and WBC normal; platelet count 230 ×10^9/L. Platelet aggregation studies show markedly reduced aggregation to ADP, collagen and epinephrine, but normal aggregation with ristocetin. Which diagnosis is most likely?
---
- (A) Bernard-Soulier syndrome
- (B) Glanzmann thrombasthenia
- (C) von Willebrand disease type 2B
- (D) Storage-pool (delta-granule) deficiency
💡 Click to Reveal Answer & Nelson Rationale
Option B (Glanzmann thrombasthenia)
Correct This disorder is caused by deficiency or dysfunction of the platelet GPIIb/IIIa (integrin αIIbβ3) receptor, which mediates fibrinogen binding and platelet–platelet aggregation. The hallmark laboratory feature is absent aggregation with all physiological agonists (ADP, collagen, epinephrine, arachidonic acid), while ristocetin aggregation remains normal because this pathway tests vWF–GPIb binding, which is intact.
A child presents with mucocutaneous bleeding. The peripheral blood smear (image below) shows markedly enlarged (giant) platelets and a reduced platelet count. Which inherited platelet disorder does this smear most strongly suggest?
![[9cddfabc_1759994943900_1759994944.png]]
---
- (A) Glanzmann thrombasthenia
- (B) Bernard-Soulier syndrome
- (C) Wiskott-Aldrich syndrome
- (D) Immune thrombocytopenia (ITP)
💡 Click to Reveal Answer & Nelson Rationale
Option B (Bernard-Soulier syndrome)
Bernard-Soulier syndrome results from deficiency of the GPIb-IX-V receptor complex, essential for platelet adhesion to vWF. The characteristic peripheral smear finding is macrothrombocytopenia (giant platelets with reduced platelet count). Laboratory testing shows absent ristocetin-induced aggregation, distinguishing it from Glanzmann thrombasthenia and von Willebrand disease.
A 12-year-old boy presents with pallor and recurrent infections. CBC shows Hb 6 g/dL, ANC 400/µL, Platelets 20 ×10^9/L. Bone marrow aspirate is performed, and the image is shown below. What is the most likely diagnosis?
---
- (A) Aplastic anemia
- (B) Acute lymphoblastic leukemia
- (C) Myelodysplastic syndrome
- (D) Megaloblastic anemia
💡 Click to Reveal Answer & Nelson Rationale
Option A (Aplastic anemia)
Bone marrow in aplastic anemia is markedly hypocellular, often <25%, with replacement by fat cells and stromal elements. This correlates with pancytopenia in the peripheral blood.
Blood smear shows hypochromic microcytic RBCs with pencil cells. Most likely diagnosis?
---
- (A) Iron deficiency
- (B) Folate deficiency
- (C) B12 deficiency
- (D) Hemolytic anemia
💡 Click to Reveal Answer & Nelson Rationale
Option A (Iron deficiency)
The classic peripheral smear of iron deficiency shows microcytic, hypochromic red cells and poikilocytes such as pencil cells (elongated erythrocytes) and target cells in some cases. These morphologic changes reflect impaired hemoglobinization of erythrocytes. In early iron deficiency, the smear may show anisocytosis and increased central pallor; with progression, microcytosis and hypochromia become more pronounced.
Peripheral smear of a vegetarian child with anemia shows macro-ovalocytes and hypersegmented neutrophils. Likely deficiency?
---
- (A) Folate
- (B) B12
- (C) Iron
- (D) Vitamin C
💡 Click to Reveal Answer & Nelson Rationale
Option B (B12)
Macro-ovalocytes and hypersegmented neutrophils are hallmark features of megaloblastic anemia, which may be due to folate or vitamin B12 deficiency. In a vegetarian child with neurologic symptoms or risk factors for low dietary B12, vitamin B12 deficiency is highly likely. On the biochemical level, B12 deficiency impairs DNA synthesis in rapidly dividing marrow cells causing large, immature red cell precursors (megaloblasts) and the characteristic peripheral smear changes.
A 6-year-old child is evaluated for anemia. Peripheral smear is shown. Which of the following is the most likely underlying cause?
---
- (A) Sickle cell disease
- (B) β-thalassemia
- (C) Lead toxicity
- (D) G6PD deficiency
💡 Click to Reveal Answer & Nelson Rationale
Option A (Sickle cell disease)
The peripheral smear shows Howell-Jolly bodies, which are small intraerythrocytic nuclear remnants. Normally, these are removed by the spleen. Their presence suggests asplenia or functional hyposplenism. In children, an important cause is sickle cell disease, where repeated splenic infarction leads to functional asplenia, predisposing to severe infections with encapsulated organisms such as pneumococcus.
A child with anemia has peripheral smear shown in the image. This finding may be seen in all of the following conditions, except
---
- (A) Thalassemia
- (B) Lead toxicity
- (C) Myelodysplasia
- (D) Sideroblastic anemia
💡 Click to Reveal Answer & Nelson Rationale
Option D (Sideroblastic anemia)
Basophilic stippling represents punctate ribosomal RNA remnants within red cells. It is classically associated with lead toxicity, and may also be seen in thalassemia and myelodysplasia. Sideroblastic anemia is a close mimic because it is also a disorder of heme synthesis and causes microcytic anemia, but the characteristic marrow finding is ring sideroblasts, not basophilic stippling as the key peripheral smear association in this table.
![[d18d3564_large_table__3__1786210986.png]]
A child is found to have anemia on CBC. Peripheral smear is shown. All of the following are recognized causes of this red cell morphology, except
---
- (A) Aplastic anemia
- (B) Liver disease
- (C) Kidney disease
- (D) Newborns
💡 Click to Reveal Answer & Nelson Rationale
Option C (Kidney disease)
The smear shows macrocytes, which are enlarged red blood cells. Recognized causes of macrocytosis in children include vitamin B12 or folate deficiency, Diamond-Blackfan anemia, Fanconi anemia, aplastic anemia, liver disease, Down syndrome, hypothyroidism, and the normal newborn period. Kidney disease more typically causes a normocytic anemia due to reduced erythropoietin production, not classic macrocytosis.
![[17c9b067_large_table__4__1786211228.png]]
A 2-month-old infant is evaluated for severe transfusion-dependent anemia. CBC shows macrocytosis with reticulocytopenia; leukocyte and platelet counts are intermittently low. He was initially labeled as having Diamond-Blackfan anemia because of early-onset macrocytic anemia, but he also has failure to thrive, chronic diarrhea, malabsorption, and evidence of exocrine pancreatic dysfunction. Bone marrow morphology is shown. Which investigation would best distinguish the more likely diagnosis from Diamond-Blackfan anemia?
---
- (A) Erythrocyte adenosine deaminase level
- (B) Ribosomal protein gene panel
- (C) Mitochondrial DNA deletion analysis
- (D) Serum vitamin B12 and folate levels
💡 Click to Reveal Answer & Nelson Rationale
Option C (Mitochondrial DNA deletion analysis)
This infant has features of Pearson syndrome, which can closely mimic Diamond-Blackfan anemia because both may present in early infancy with severe macrocytic anemia and reticulocytopenia. The clues against classical DBA are intermittent neutropenia or thrombocytopenia and multisystem disease, especially failure to thrive, malabsorption, and exocrine pancreatic dysfunction. The marrow image shows vacuolated erythroid/myeloid precursors and ringed sideroblasts, supporting Pearson syndrome. The best differentiating test is demonstration of a large heteroplasmic mitochondrial DNA deletion.
![[bb54b3d7_1786086064287_1786086066.png]]
A 5-year-old boy presents with pallor, mild icterus, and hepatosplenomegaly. CBC shows hypochromic microcytic anemia with very high RDW. Serum iron and transferrin saturation are increased. Bone marrow iron stain is shown. A congenital nonsyndromic X-linked form is suspected. Which treatment may produce hematologic response in a subset of patients?
---
- (A) Thiamine
- (B) Folinic acid
- (C) Hydroxocobalamin
- (D) Pyridoxine
💡 Click to Reveal Answer & Nelson Rationale
Option D (Pyridoxine)
The image shows ring sideroblasts, supporting sideroblastic anemia. The most common nonsyndromic congenital sideroblastic anemia is X-linked and is usually caused by pathogenic variants in ALAS2, which encodes erythroid 5-aminolevulinic acid synthase, the rate-limiting enzyme in heme synthesis. Pyridoxal phosphate is an important cofactor for this enzyme, so a subset of patients with hereditary sideroblastic anemia responds to pyridoxine therapy.
![[ae526d53_1786086220017_1786086222.png]]
A child is evaluated for chronic hemolytic anemia. Peripheral smear is shown. Laboratory evaluation shows macrocytosis, low MCHC, decreased osmotic fragility, and increased red cell Na⁺ content. Splenectomy is being considered but the hematologist advises against it because of the risk of major postsplenectomy thrombosis. Which diagnosis best fits this profile?
---
- (A) Hereditary xerocytosis
- (B) Hereditary hydrocytosis
- (C) Hereditary spherocytosis
- (D) Southeast Asian ovalocytosis
💡 Click to Reveal Answer & Nelson Rationale
Option B (Hereditary hydrocytosis)
The smear and laboratory profile are most consistent with hereditary hydrocytosis, a rare dominant disorder of altered erythrocyte volume regulation. It is characterized by swollen stomatocytic erythrocytes, macrocytosis, low MCHC, increased red cell water and sodium content, and decreased osmotic fragility. A very high-yield management point is that splenectomy is not recommended because significant postsplenectomy major thromboses have been reported.
![[067be343_1786086410275_1786086413.png]]
A child with chronic hemolytic anemia has the peripheral smear shown. The abnormal red cells have irregular circumferential pointed projections. Which of the following disorders is classically associated with this morphology?
---
- (A) Pyruvate kinase deficiency
- (B) Huntington disease
- (C) Hereditary spherocytosis
- (D) Pantothenate kinase-associated neurodegeneration
💡 Click to Reveal Answer & Nelson Rationale
Option D (Pantothenate kinase-associated neurodegeneration)
The smear shows acanthocytes, also called spur cells. Acanthocytosis is characterized by red cells with irregular, unevenly distributed pointed projections. It is associated with neuroacanthocytosis syndromes, including pantothenate kinase-associated neurodegeneration, chorea-acanthocytosis, McLeod syndrome, and Huntington disease-like 2. Pantothenate kinase-associated neurodegeneration may present with dystonia, rigidity, chorea, dysarthria, spasticity, retinopathy, and cognitive or behavioral changes.
**Table:** Hereditary Acanthocytosis Syndromes
![[b0862a83_medium_table__5__1786211352.png]]
A 10-month-old infant presents with painful swelling of both hands and feet. There is no history of trauma. Radiographs are shown. The child is later found to have a hemoglobinopathy. Which of the following statements is most appropriate?
---
- (A) It is usually due to bacterial osteomyelitis and requires 4-6 weeks of IV antibiotics
- (B) It is often the first manifestation of sickle cell anemia in infancy
- (C) It is most commonly seen after 5 years of age due to repeated marrow infarction
- (D) It is diagnostic of acute splenic sequestration in sickle cell disease
💡 Click to Reveal Answer & Nelson Rationale
Option B (It is often the first manifestation of sickle cell anemia in infancy)
The image and clinical scenario are consistent with sickle cell dactylitis, also called hand-foot syndrome. It is often the first manifestation of pain in infants and young children with sickle cell anemia and occurs in about half of children by 2 years of age. It usually presents with symmetric or asymmetric swelling of the hands and/or feet and can be mistaken for osteomyelitis
![[bde9c53a_1786086650302_1786086652.png]]
A 5-year-old boy develops jaundice and dark urine after receiving an oxidant drug. Peripheral smear is shown. Enzyme testing during the acute episode is only low-normal, but the reticulocyte count is markedly elevated. What is the best next step regarding diagnostic testing?
---
- (A) Exclude the diagnosis because enzyme activity is not frankly low
- (B) Repeat the enzyme assay after a few weeks
- (C) Confirm diagnosis by osmotic fragility testing
- (D) Perform methylene blue challenge testing immediately
💡 Click to Reveal Answer & Nelson Rationale
Option B (Repeat the enzyme assay after a few weeks)
The smear shows changes of oxidant hemolysis, such as bite cells. During an acute hemolytic episode, older enzyme-deficient RBCs are preferentially destroyed, leaving predominantly reticulocytes and young RBCs. These younger cells have higher enzyme activity, so testing performed immediately after hemolysis may appear falsely normal or low-normal. Therefore, when clinical suspicion remains high and reticulocytosis is marked, the enzyme assay should be repeated after a few weeks.
![[c8766b9e_1786086787555_1786086790.png]]
A 13-year-old child with progressive pancytopenia has the clinical findings shown in the image. Genetic testing confirms a telomere biology disorder. Which of the following systemic complications is characteristically associated with this condition?
---
- (A) Exocrine pancreatic insufficiency with metaphyseal dysplasia
- (B) Renal medullary carcinoma with hyposthenuria
- (C) Severe neutropenia with pancreatic fatty replacement
- (D) Pulmonary fibrosis with reduced diffusion capacity
💡 Click to Reveal Answer & Nelson Rationale
Option D (Pulmonary fibrosis with reduced diffusion capacity)
The image is suggestive of dyskeratosis congenita, an inherited telomere biology disorder. In addition to progressive bone marrow failure, affected patients may develop systemic complications such as pulmonary fibrosis, liver disease, malignancy, premature graying, and other features of telomere dysfunction. Pulmonary involvement may manifest as restrictive lung disease or reduced diffusion capacity.
![[2d68be0c_1786086930807_1786086933.png]]
A 9-year-old boy is
evaluated for persistent anemia and progressive fatigue. Examination shows
short stature, patchy hyperpigmentation, and bilateral abnormalities of the thumbs.
He also has microcephaly. Which of the following additional physical findings
would most strongly support the same underlying diagnosis?
---
- (A) Microphthalmia
- (B) Shield chest
- (C) Leukoplakia
- (D) Retinopathy
💡 Click to Reveal Answer & Nelson Rationale
Option A (Microphthalmia)
The
combination of anemia with short stature, hyperpigmentation, thumb
abnormalities, and microcephaly suggests **Fanconi anemia**. Microphthalmia
is another characteristic physical finding associated with Fanconi anemia. The
presence of multiple congenital anomalies in a child being evaluated for anemia
should raise suspicion for an inherited bone marrow failure syndrome rather than
an isolated nutritional anemia.<o:p></o:p>
**<font color="#54acd2">
</font>**
<b><font color="#54acd2">
A 12-year-old boy is
evaluated for chronic anemia. Examination reveals reticulate areas of abnormal
skin pigmentation and progressive dystrophic changes involving several
fingernails. There are no limb reduction defects. Which of the following
additional findings would most strongly support the underlying diagnosis?
---
- (A) Microphthalmia with short stature
- (B) Thenar eminence hypoplasia
- (C) Blocked lacrimal glands
- (D) Café-au-lait macules
💡 Click to Reveal Answer & Nelson Rationale
Option C (Blocked lacrimal glands)
The
combination of abnormal skin pigmentation and dystrophic nails in a child with
chronic anemia should raise suspicion for **dyskeratosis congenita**, an
inherited bone marrow failure syndrome. Blocked lacrimal glands are another
physical finding associated with this disorder. Oral leukoplakia is also an
important finding but is deliberately omitted from the stem because its
inclusion would make the diagnosis considerably more straightforward.<o:p></o:p>
**<font color="#54acd2">
</font>**
<b><font color="#54acd2">
A 10-year-old boy with
chronic anemia presents with progressive gait difficulty. Examination
demonstrates impaired vibration and position sense in both lower limbs. He has
no skeletal deformities or organomegaly. Which associated finding would most
strongly help distinguish the likely nutritional deficiency from another
deficiency capable of producing similar neurologic signs?
---
- (A) Café-au-lait spots
- (B) Spoon nails
- (C) Vitiligo
- (D) Telangiectasia
💡 Click to Reveal Answer & Nelson Rationale
Option C (Vitiligo)
Posterior
column signs and ataxia may occur with deficiencies of both vitamin B₁₂ and
vitamin E, making the neurologic examination alone potentially misleading.
Vitiligo is an examination finding associated with vitamin B₁₂ deficiency and
therefore provides an additional clue favoring B₁₂ deficiency in a child with
anemia and posterior column dysfunction.<o:p></o:p>
**<font color="#54acd2">
</font>**
<b><font color="#54acd2">
A 9-year-old child is
evaluated for progressive fatigue and suspected anemia. During the general
physical examination, the consultant asks the resident to identify the site
that is least useful for detecting clinical pallor. Which of the following is
the least reliable site?
---
- (A) Tongue
- (B) Nail beds
- (C) Palmar creases
- (D) Buccal mucosa
💡 Click to Reveal Answer & Nelson Rationale
Option D (Buccal mucosa)
Clinical
pallor is best assessed at sites where reduced hemoglobin concentration is
readily appreciated because of the rich vascular supply and minimal
pigmentation. Recommended sites include the tongue, nail beds, conjunctiva,
palms, and palmar creases. Although the oral cavity is examined routinely, the buccal
mucosa is not considered one of the standard or most reliable sites for
assessing pallor. The discriminating feature in this question is distinguishing
the tongue from the more general oral mucosa.<o:p></o:p>
**<font color="#54acd2">
</font>**
<b><font color="#54acd2">
A 10-year-old child with
gradually progressive anemia is brought to the outpatient department because of
increasing fatigue. The consultant explains that the child’s hemoglobin has
fallen slowly over several months. In the absence of any disease-specific
manifestations, clinical features attributable solely to anemia generally
become apparent when the hemoglobin concentration falls below approximately
---
- (A) 10–11 g/dL
- (B) 9–10 g/dL
- (C) 7–8 g/dL
- (D) 5–6 g/dL
💡 Click to Reveal Answer & Nelson Rationale
Option C (7–8 g/dL)
The
severity of symptoms in anemia depends not only on the hemoglobin concentration
but also on the rate of decline. Children with slowly developing anemia often
compensate well through physiological adaptations, and clinical manifestations
attributable solely to anemia are usually absent until the hemoglobin
concentration falls below approximately 7–8 g/dL. Early manifestations include
pallor, irritability, sleepiness, and reduced exercise tolerance. With
progressively severe anemia, tachycardia, tachypnea, exertional dyspnea,
cardiac dilatation, and eventually high-output cardiac failure may develop. The
discriminating feature in this question is the emphasis on slowly progressive
anemia, allowing physiological compensation.<o:p></o:p>
**<font color="#54acd2">
</font>**
<b><font color="#54acd2">
A 7-year-old girl with
chronic anemia is noted to have craniofacial abnormalities and a congenital
cleft lip and palate. Examination also reveals a shield-shaped chest with
widely spaced nipples. Which of the following upper-limb abnormalities would be
most consistent with the underlying hematologic disorder?
---
- (A) Bilateral absent thumbs
- (B) Hypoplastic radius with absent thumb
- (C) Thenar eminence hypoplasia with a triphalangeal thumb
- (D) Radial ray defect with hypoplastic thumb
💡 Click to Reveal Answer & Nelson Rationale
Option C (Thenar eminence hypoplasia with a triphalangeal thumb)
The
combination of cleft lip and palate and a shield chest with widely spaced
nipples suggests Diamond-Blackfan anemia. Characteristic upper-limb
abnormalities in Diamond-Blackfan anemia include thenar eminence hypoplasia and
a triphalangeal thumb. Recognition of these congenital abnormalities can
provide an important clue to the underlying hematologic disorder.<o:p></o:p>
**<font color="#54acd2">
</font>**
<b><font color="#54acd2">
A 7-year-old boy is
evaluated for pallor and poor school performance. Examination reveals a smooth
tongue, fissuring at the angles of the mouth, and spoon-shaped fingernails.
Which of the following additional examination findings would most strongly
support the same nutritional deficiency?
---
- (A) Perifollicular hemorrhages
- (B) Blue sclera
- (C) Posterior column signs
- (D) Corneal xerosis
💡 Click to Reveal Answer & Nelson Rationale
Option B (Blue sclera)
The
combination of a smooth tongue, angular stomatitis, and spoon-shaped nails or
koilonychia is suggestive of iron deficiency. Blue sclera is another recognized
examination finding associated with iron deficiency and therefore provides
additional support for the same nutritional deficiency.<o:p></o:p>
**<font color="#54acd2">
</font>**
<b><font color="#54acd2">
A 9-year-old boy is
evaluated for pallor. His hemoglobin is 7.8 g/dL and MCV is 68 fL. The
reticulocyte count is markedly elevated. Which of the following diagnoses is
most consistent with this combination of findings?
---
- (A) Copper deficiency
- (B) Sideroblastic anemia
- (C) Hemoglobin C disease
- (D) Anemia of chronic disease
💡 Click to Reveal Answer & Nelson Rationale
Option C (Hemoglobin C disease)
The
diagnostic approach to anemia should integrate the MCV with the reticulocyte
response. Microcytic anemia with a high reticulocyte count suggests an anemia
in which marrow production is appropriately increased, particularly a
hemoglobinopathy or hemolytic process. Hemoglobin C disease is included among
the causes of microcytic anemia with an increased reticulocyte count.<o:p></o:p>
In contrast, nutritional deficiencies, impaired heme
synthesis, and anemia of chronic disease generally produce an inadequate
reticulocyte response relative to the degree of anemia.
![[c62c023d_image_05e9c133a8164bb297e66a4fbfeb7f43.png]]
<b><font color="#54acd2">
A pediatrician screens
four children for anemia using the WHO hemoglobin cutoffs. Which of the
following children would be classified as anemic?
---
- (A) A 4-year-old child with hemoglobin 11.0 g/dL
- (B) A 7-year-old child with hemoglobin 11.4 g/dL
- (C) A 12-year-old child with hemoglobin 12.0 g/dL
- (D) A 13-year-old child with hemoglobin 12.1 g/dL
💡 Click to Reveal Answer & Nelson Rationale
Option B (A 7-year-old child with hemoglobin 11.4 g/dL)
The
WHO hemoglobin cutoff for defining anemia varies with age. For children aged 6
months to 5 years, anemia is defined as hemoglobin <11.0 g/dL; for children
aged 5–11 years, the cutoff is <11.5 g/dL; and for children aged 12–13 years,
it is <12.0 g/dL. Therefore, a 7-year-old child with hemoglobin 11.4 g/dL
meets the definition of anemia.
![[72d3c927_image_b86253de5f904c2ea291e8b0f50dfdf6.png]]
<b><font color="#54acd2">
A
3-year-old child with severe pallor is admitted with easy fatigability and
tachycardia. Examination reveals a hyperdynamic precordium and a systolic flow
murmur. Hemoglobin is 5.4 g/dL. Which of the following electrocardiographic
findings is most likely in this child?<o:p
---
- (A) Normal QRS complexes with ST-segment depression and flattened or inverted T waves
- (B) Low-voltage QRS complexes with ST-segment elevation and tall T waves
- (C) Prolonged QRS complexes with diffuse ST-segment elevation and T-wave inversion
- (D) High-voltage QRS complexes with shortened ST segments and peaked T waves
💡 Click to Reveal Answer & Nelson Rationale
Option A (Normal QRS complexes with ST-segment depression and flattened or inverted T waves)
Severe
anemia produces compensatory cardiovascular changes because reduced
oxygen-carrying capacity increases cardiac output. The resulting high-output
state may manifest clinically with tachycardia, a hyperdynamic circulation,
prominent systolic flow murmurs, and a collapsing pulse. According to the
reference, electrocardiographic abnormalities may occur in approximately 30% of
patients when the hemoglobin is <6 g/dL. The characteristic ECG findings are
normal QRS complexes, ST-segment depression, and flattening or inversion of T
waves.<o:p></o:p>
**<font color="#54acd2">
</font>**
<b><font color="#54acd2">
A 10-year-old boy is
evaluated for gradually progressive pallor. Despite a markedly reduced
hemoglobin concentration, he remains relatively comfortable at rest. Another
child with a similar hemoglobin concentration following an acute
gastrointestinal bleed develops prominent weakness, tachycardia, and dyspnea.
Which of the following best explains the difference in clinical manifestations
between the two children?
---
- (A) Symptoms are determined predominantly by the absolute hemoglobin concentration
- (B) Symptoms are influenced by the rate of development of anemia and cardiovascular status
- (C) Symptoms are determined primarily by the degree of reduction in hematocrit
- (D) Symptoms are influenced mainly by the duration of anemia and reticulocyte response
💡 Click to Reveal Answer & Nelson Rationale
Option B (Symptoms are influenced by the rate of development of anemia and cardiovascular status)
The
hemoglobin level at which symptoms of anemia develop depends principally on the
rate at which the anemia develops and the state of the cardiovascular system.
Slowly progressive anemia permits compensatory adaptations, allowing a child to
tolerate a substantially reduced hemoglobin concentration with relatively few
symptoms. In rapidly developing anemia, such as acute hemorrhage, there is
insufficient time for such adaptation, and symptoms may therefore appear at a
higher hemoglobin concentration.<o:p></o:p>
**<font color="#54acd2">
</font>**
<b><font color="#54acd2">
A 10-year-old boy with
long-standing anemia is found to have microcytosis. The reticulocyte response
is not increased. Serum iron is reduced, but ferritin is preserved and total
iron-binding capacity is not elevated. There is no obvious source of blood loss.
Which investigation would be most useful as the next step in etiologic
evaluation?
---
- (A) Hemoglobin electrophoresis or HPLC
- (B) Repeat serum ferritin after a therapeutic trial of iron
- (C) Bone marrow examination for ring sideroblasts
- (D) Erythrocyte sedimentation rate and C-reactive protein
💡 Click to Reveal Answer & Nelson Rationale
Option D (Erythrocyte sedimentation rate and C-reactive protein)
In
the evaluation of microcytic anemia, the reticulocyte count and iron profile
help determine the next diagnostic step. A normal or reduced reticulocyte
response accompanied by low serum iron, normal or increased ferritin, and
normal or low total iron-binding capacity (TIBC) suggests impaired iron
availability rather than uncomplicated iron deficiency. In this setting, erythrocyte
sedimentation rate (ESR) and C-reactive protein (CRP) should be assessed to
look for an underlying inflammatory process. In contrast, iron deficiency is
characterized by low serum iron, low ferritin, and increased TIBC.
![[961269a8_image_b49229f296e14b9ea9ad3659cea067d1.png]]
<o:p>
</o:p>
<o:p>
</o:p>
<b><font color="#54acd2">
A
13-year-old boy undergoes evaluation for anemia. His red cell indices show an
MCV of 84 fL and MCH of 29 pg. Which of the following interpretations is most
appropriate when these values are compared with normal age-related red cell
indices?<o:p
---
- (A) Both MCV and MCH are below the expected values for age and sex
- (B) MCV is below the expected value, while MCH is appropriate for age
- (C) MCV is appropriate for age, while MCH is below the expected value
- (D) Both MCV and MCH are within the expected range for age and sex
💡 Click to Reveal Answer & Nelson Rationale
Option B (MCV is below the expected value, while MCH is appropriate for age)
Red
cell indices vary with age and, during adolescence, with sex. According to the
table, boys aged 12–18 years have a mean MCV of approximately 88 fL and a mean
MCH of 30 pg. Therefore, an MCV of 84 fL is below the listed mean for this age
and sex, while an MCH of 29 pg is also slightly below the listed mean.
![[6ed0d036_image_a255f2e249034dba8bd8033a425d9add.png]]
<b><font color="#54acd2">
A 12-year-old boy is
evaluated for persistent anemia. Hemoglobin is 7.8 g/dL with an MCV of 88 fL.
The reticulocyte response is inappropriately low for the degree of anemia.
Serum iron is within the normal range. Renal and liver function tests and
thyroid profile are normal. There is no clinical evidence of blood loss or
hemolysis. Which of the following is the most appropriate next step in
evaluation?
---
- (A) Hemoglobin electrophoresis with HPLC
- (B) Serum ferritin and total iron-binding capacity
- (C) Bone marrow biopsy
- (D) Direct antiglobulin test with hemolysis workup
💡 Click to Reveal Answer & Nelson Rationale
Option C (Bone marrow biopsy)
This
child has normocytic anemia with an inappropriately low reticulocyte response,
indicating impaired red cell production rather than increased peripheral
destruction or blood loss. In the diagnostic approach to normocytic anemia, a
normal or reduced reticulocyte count is followed by assessment of serum iron
and screening for renal, hepatic, and endocrine disease. When serum iron is
normal or increased and screening for these systemic disorders is negative,
bone marrow biopsy is the appropriate next investigation. Bone marrow
examination can identify infiltrative disorders such as leukemia, metastasis,
or myelofibrosis, as well as aplastic anemia, pure red cell aplasia,
myelodysplastic syndrome, and congenital dyserythropoietic anemia.
![[8d62eac4_image_9e10f7facbe34763acf00f577bbf8167.png]]
<b><font color="#54acd2">
A 13-year-old boy has
persistent macrocytosis. Peripheral smear shows no hypersegmented neutrophils,
and the reticulocyte count is low. Liver and thyroid evaluation is normal.
Which of the following is the most likely diagnosis to be identified on further
evaluation?
---
- (A) Congenital dyserythropoietic anemia
- (B) Transcobalamin II deficiency
- (C) Chronic hemolytic anemia
- (D) Drug-induced macrocytosis
💡 Click to Reveal Answer & Nelson Rationale
Option A (Congenital dyserythropoietic anemia)
The absence of hypersegmented
neutrophils makes a typical megaloblastic process less likely. In
nonmegaloblastic macrocytosis, the reticulocyte count helps guide further
evaluation. An increased reticulocyte count suggests hemolysis or hemorrhage,
whereas a decreased reticulocyte count indicates impaired erythropoiesis. When
liver disease and hypothyroidism have been excluded, bone marrow examination is
indicated. Important disorders identified at this stage include aplastic
anemia, red cell aplasia, congenital dyserythropoietic anemia, myelodysplastic
syndrome, and sideroblastic anemia. Among the given options, congenital
dyserythropoietic anemia best fits this diagnostic pathway.
![[3e190b1b_image_61a780c7bd034b47a901d91e1f1db5f0.png]]
<b><font color="#54acd2">
A 9-year-old boy with
anemia has a reticulocyte count of 6%. His hemoglobin is 7.5 g/dL. Assuming a
normal hemoglobin of 15 g/dL for calculation, what is the corrected
reticulocyte count, and how should the marrow response be interpreted?
---
- (A) 2%; inadequate marrow response
- (B) 3%; increased marrow response
- (C) 5%; increased marrow response
- (D) 6%; increased marrow response
💡 Click to Reveal Answer & Nelson Rationale
Option B (3%; increased marrow response)
In
anemia, the observed reticulocyte percentage may appear disproportionately high
because the circulating red cell mass is reduced. The reticulocyte count should
therefore be corrected according to the severity of anemia.<o:p></o:p>
Corrected
reticulocyte count = Reticulocyte % × patient hemoglobin / normal hemoglobin<o:p></o:p>
For
this child, the corrected reticulocyte count is 6 × 7.5/15 = **3%**. Thus,
the corrected reticulocyte count is increased, indicating an appropriate marrow
response and suggesting increased red cell loss or destruction rather than
decreased erythropoiesis.<o:p></o:p>
**<font color="#54acd2">
</font>**
<b><font color="#54acd2">
A 5-month-old
exclusively breastfed infant and an age-matched infant predominantly fed
unfortified cow milk are compared with respect to dietary iron. Although the
absolute iron content of breast milk is low, the breastfed infant is relatively
better protected against iron deficiency. Which of the following best explains
this observation?
---
- (A) Breast milk contains more total iron than cow milk
- (B) Cow milk iron undergoes greater intestinal sequestration
- (C) Breast milk iron has greater gastrointestinal bioavailability
- (D) Cow milk contains predominantly nonabsorbable ferric iron
💡 Click to Reveal Answer & Nelson Rationale
Option C (Breast milk iron has greater gastrointestinal bioavailability)
The
absolute iron content of breast milk is relatively low, but iron in breast milk
is more bioavailable than iron in cow milk. Consequently, a greater proportion
of the available iron can be absorbed and utilized by the infant. The amount of
a nutrient present in milk therefore does not necessarily predict how
effectively it will meet the infant’s physiologic requirement.<o:p></o:p>
Cow
milk predisposes infants to iron deficiency through additional mechanisms. Its
higher calcium concentration can interfere with iron absorption, and
susceptible infants may develop gastrointestinal blood loss associated with cow
milk exposure.
<o:p>
</o:p>
<b><font color="#54acd2">
A 3-year-old child is
evaluated for progressive pallor and poor appetite. Peripheral smear shows
microcytosis, anisocytosis, and poikilocytosis. Several erythrocytes
demonstrate increased central pallor. Which of the following findings defines
hypochromia on peripheral smear?
---
- (A) Central pallor involving more than one-third of the red cell diameter
- (B) Central pallor involving more than one-half of the red cell diameter
- (C) Central pallor involving less than one-third of the red cell diameter
- (D) Central pallor involving exactly one-third of the red cell diameter
💡 Click to Reveal Answer & Nelson Rationale
Option A (Central pallor involving more than one-third of the red cell diameter)
Hypochromia
reflects reduced hemoglobinization of red blood cells and is recognized
morphologically by an increase in the central pale area of the erythrocyte.
Normally, central pallor occupies approximately one-third of the red cell
diameter. Central pallor greater than one-third of the red cell diameter is
considered hypochromia. Iron deficiency anemia typically produces microcytic,
hypochromic erythrocytes and may also be accompanied by anisocytosis and
poikilocytosis.
![[41f49009_image_ad8a4ae2a3364f7bb72e5bcb2993ce3f.png]]
<b><font color="#54acd2">
A 6-year-old boy with
iron deficiency anemia is reviewed 4 weeks after initiation of oral elemental
iron therapy. Compliance has been confirmed, and there is no evidence of
ongoing blood loss. Which of the following findings would **most strongly**
justify switching to parenteral iron therapy?
---
- (A) Failure to achieve the expected rise in hemoglobin despite adequate oral iron therapy
- (B) Persistence of microcytic hypochromic erythrocytes on peripheral smear after 4–6 weeks of oral iron therapy
- (C) Persistence of low serum ferritin after 4 weeks of oral iron therapy
- (D) Persistence of an elevated red cell distribution width after 4 weeks of therapy
💡 Click to Reveal Answer & Nelson Rationale
Option A (Failure to achieve the expected rise in hemoglobin despite adequate oral iron therapy)
Oral
iron is the treatment of choice for most children with iron deficiency anemia.
An appropriate hematologic response is expected following an adequate
therapeutic trial. Failure to achieve the expected rise in hemoglobin despite
adequate dosing, good compliance, and absence of ongoing blood loss suggests
treatment failure due to causes such as poor absorption, intolerance, or an
alternative diagnosis. In such patients, parenteral iron therapy should be
considered while evaluating the underlying cause.
<o:p>
</o:p>
<b><font color="#54acd2">
A 30-kg child with iron deficiency
anemia has failed an adequate trial of oral iron therapy and is planned for
intravenous iron replacement. The calculated total cumulative iron requirement
is 900 mg. Which of the following is the most appropriate dosing schedule for
parenteral iron?
---
- (A) 450 mg every 7 days until the cumulative dose is administered
- (B) 300 mg every 3–7 days until the cumulative dose is administered
- (C) 250 mg every 3–7 days until the cumulative dose is administered
- (D) 600 mg followed by 300 mg after 3 days
💡 Click to Reveal Answer & Nelson Rationale
Option B (300 mg every 3–7 days until the cumulative dose is administered)
Parenteral
iron should be administered after calculating the total cumulative iron deficit.
The cumulative dose should be divided into multiple doses administered every
3–7 days. To minimize adverse reactions, the maximum recommended single dose is
300 mg or 7 mg/kg, whichever is lower. Therefore, a child requiring 900 mg
should receive 300 mg every 3–7 days until the total calculated dose has been
administered.
![[9d781e53_image_d86bae7011e34495bd6335954c41e12a.png]]
<b><font color="#54acd2">
A 5-year-old boy is
diagnosed with nutritional iron deficiency anemia and started on oral elemental
iron therapy. At follow-up, the pediatrician explains the expected hematologic
response and the recommended duration of treatment. Which of the following combinations
is most appropriate?
---
- (A) Reticulocyte response in 5–7 days; continue oral iron for 4–6 weeks after correction of anemia
- (B) Reticulocyte response in 72–96 hours; continue oral iron for 4–6 weeks after correction of anemia
- (C) Reticulocyte response in 5–7 days; continue oral iron for 4–6 months after correction of anemia
- (D) Reticulocyte response in 72–96 hours; continue oral iron for 4–6 months after correction of anemia
💡 Click to Reveal Answer & Nelson Rationale
Option D (Reticulocyte response in 72–96 hours; continue oral iron for 4–6 months after correction of anemia)
The
earliest hematologic evidence of an adequate response to oral iron therapy is
an increase in the reticulocyte count within 72–96 hours of initiating
treatment. A rise in hemoglobin follows subsequently over the next few weeks.
Once anemia has been corrected, iron therapy should not be discontinued
immediately. Oral iron should be continued for 4–6 months to replenish depleted
body iron stores and reduce the risk of recurrence.
<b><font color="#54acd2">
A 12-year-old boy with
transfusion-dependent β-thalassemia major is started on deferoxamine for
transfusional iron overload. Three days later, his parents notice orange
discoloration of his urine. Which of the following is the most appropriate
explanation for this finding?
---
- (A) Excessive urinary iron excretion due to over-chelation requiring dose reduction
- (B) Urinary excretion of the ferrioxamine (iron–deferoxamine) complex
- (C) Early renal toxicity secondary to deferoxamine therapy
- (D) Hemoglobinuria due to intravascular hemolysis precipitated by chelation
💡 Click to Reveal Answer & Nelson Rationale
Option B (Urinary excretion of the ferrioxamine (iron–deferoxamine) complex)
Deferoxamine
(DFO) chelates ferric iron to form the ferrioxamine complex, which is excreted
in the urine. As a result, orange or reddish-orange discoloration of urine is
an expected pharmacologic effect and does not indicate toxicity or treatment
failure. Patients should be counseled regarding this benign finding before
starting therapy.<o:p></o:p>
**<font color="#54acd2">
</font>**
<b><font color="#54acd2">
A
14-year-old boy with transfusion-dependent β-thalassemia major is referred for
disability certification to avail educational concessions and social welfare
benefits. Under the Rights of Persons with Disabilities (RPWD) Act, 2016, which
of the following hematological disorders is also recognized as a specified
disability?<o:p
---
- (A) Severe aplastic anemia
- (B) Hereditary elliptocytosis
- (C) Hereditary spherocytosis
- (D) Hemophilia
💡 Click to Reveal Answer & Nelson Rationale
Option D (Hemophilia)
The
Rights of Persons with Disabilities (RPWD) Act, 2016 recognizes thalassemia,
hemophilia, and sickle cell disease as specified disabilities. Individuals with
these disorders are eligible for disability certification and can avail
themselves of benefits provided under the Act, including educational,
employment, and social welfare provisions. Other inherited or acquired
hematological disorders, although associated with significant morbidity, are
not specifically included under the RPWD Act.
<b><font color="#54acd2">
A 9-year-old boy with
homozygous sickle cell disease is admitted with fever and pain involving the
left femur. He is treated as a vaso-occlusive crisis. After 72 hours, there is
no clinical improvement. Blood cultures are sterile, and MRI demonstrates marrow
edema. Which of the following is the most appropriate next step in management?
---
- (A) Continue supportive management with opioid analgesia and reassess after 48 hours
- (B) Obtain image-guided aspiration with or without bone biopsy for microbiological culture before initiating intravenous antibiotics
- (C) Initiate empirical intravenous antibiotics and obtain image-guided aspiration with or without bone biopsy for microbiological culture
- (D) Initiate empirical intravenous antibiotics and await repeat blood culture results before considering image-guided aspiration
💡 Click to Reveal Answer & Nelson Rationale
Option C (Initiate empirical intravenous antibiotics and obtain image-guided aspiration with or without bone biopsy for microbiological culture)
Children
with sickle cell disease frequently present with bone pain due to vaso-occlusive
crisis, but osteomyelitis must be suspected when there is failure to improve
despite appropriate therapy. Clinical features, inflammatory markers, blood
cultures, and MRI findings often overlap between osteomyelitis and bone
infarction, making differentiation difficult. Because delaying treatment may
result in progression of infection, empirical intravenous antibiotics should be
started promptly. At the same time, image-guided aspiration with or without
bone biopsy for microbiological culture should be performed whenever feasible,
as culture from the affected site remains the definitive method for
establishing the diagnosis and guiding targeted antimicrobial therapy.<o:p></o:p>
**<font color="#54acd2">
</font>**
<b><font color="#54acd2">
A 13-year-old boy with
homozygous sickle cell disease is hospitalized with acute chest syndrome.
Despite supportive care, his oxygen saturation falls from 97% on admission to
92% on room air. He remains hemodynamically stable, and chest radiograph shows
a new pulmonary infiltrate. Which of the following is the most appropriate
immediate intervention?
---
- (A) Continue close monitoring with incentive spirometry because oxygen saturation remains above 90%
- (B) Start supplemental oxygen because the saturation has fallen by more than 4% from baseline
- (C) Initiate exchange transfusion because of the fall in oxygen saturation
- (D) Perform simple blood transfusion because acute chest syndrome has been diagnosed
💡 Click to Reveal Answer & Nelson Rationale
Option B (Start supplemental oxygen because the saturation has fallen by more than 4% from baseline)
Acute
chest syndrome (ACS) is a major cause of morbidity and mortality in children
with sickle cell disease. Supplemental oxygen should be initiated when there is
a
fall in oxygen saturation of ≥4% from baseline or when oxygen saturation is
<90%, even if
the absolute saturation remains above 90%. Early correction of hypoxemia is an
essential component of ACS management. Other supportive measures include
empirical antibiotics, incentive spirometry, adequate analgesia, and
transfusion when clinically indicated.
<font color="#54acd2">
![[41a17495_image_9a1e88a1f6354189830e2de880b2e8f9.png]]
</font>
<font color="#54acd2">
</font>
<b><font color="#54acd2">
A 6-year-old child with
transfusion-dependent β-thalassemia major has received regular packed red blood
cell transfusions since 2 years of age. He has normal growth parameters, normal
pubertal staging for age, and no symptoms suggestive of endocrine dysfunction.
Which of the following is the most appropriate recommendation regarding
endocrine surveillance?
---
- (A) Defer endocrine surveillance until the onset of puberty
- (B) Initiate routine endocrine surveillance after completion of 5 years of chronic transfusion therapy
- (C) Initiate routine endocrine surveillance at this visit
- (D) Begin endocrine surveillance only when growth or pubertal delay becomes evident
💡 Click to Reveal Answer & Nelson Rationale
Option C (Initiate routine endocrine surveillance at this visit)
Children
with transfusion-dependent β-thalassemia major are at risk of progressive
endocrine dysfunction due to transfusional iron overload (hemosiderosis) and
nutritional deficiencies. Iron deposition in the pituitary and endocrine glands
may result in hypothyroidism, growth hormone deficiency, delayed puberty,
hypoparathyroidism, diabetes mellitus, osteoporosis, and adrenal insufficiency.
Therefore, routine endocrine surveillance should begin at approximately 5 years
of age or after at least 3 years of chronic transfusions, whichever occurs
later in the clinical course. Surveillance should not be delayed until symptoms
or growth abnormalities develop.<o:p></o:p>
All
children require monitoring of their height, weight, pubertal assessment, and
sitting height semiannually. Bone density scans should be obtained starting in
the second decade of life given the high rate of osteopenia. Nutritional
assessments are required. Most patients need vitamin D, vitamin C, and zinc
replacement. Fertility is a growing concern among patients and should be
assessed routinely.<o:p></o:p>
**<font color="#54acd2">
</font>**
<b><font color="#54acd2">
A 1.2-kg preterm neonate
with anemia of prematurity requires an urgent packed red blood cell
transfusion. The blood bank has irradiated, prestorage leukoreduced RBC units
available immediately. CMV-seronegative units are unavailable and would require
several hours to procure. Which of the following is the most appropriate
transfusion strategy?
---
- (A) Delay transfusion until CMV-seronegative irradiated RBCs are available
- (B) Transfuse irradiated, prestorage leukoreduced CMV-untested RBCs immediately
- (C) Transfuse the available irradiated, prestorage leukoreduced RBCs and monitor for CMV infection
- (D) Request CMV-seronegative irradiated RBCs urgently and continue supportive care until available
💡 Click to Reveal Answer & Nelson Rationale
Option B (Transfuse irradiated, prestorage leukoreduced CMV-untested RBCs immediately)
Prestorage
leukoreduced packed red blood cells are the preferred RBC product for neonatal
transfusions. In very-low-birth-weight infants (<1,500 g), irradiation is
recommended to prevent transfusion-associated graft-versus-host disease.
Although some centers prefer CMV-seronegative blood to further reduce the risk
of transfusion-transmitted CMV, modern prestorage leukoreduction has reduced
this risk to a very low level. Therefore, transfusion should not be delayed
solely because CMV-seronegative blood is unavailable. In such situations, CMV-untested
prestorage leukoreduced irradiated RBCs should be transfused promptly, as
delaying transfusion may pose greater risk than the residual risk of
transfusion-transmitted CMV.
<b><font color="#54acd2">
A 12-year-old boy with
acute lymphoblastic leukemia is receiving induction chemotherapy. He has
chemotherapy-induced marrow failure and is clinically stable. There is no
active bleeding, no planned invasive procedure, and no additional hemorrhagic
risk factors. According to current pediatric platelet transfusion guidelines,
what minimum platelet count should be maintained with prophylactic platelet
transfusions?
---
- (A) >5 × 10⁹/L
- (B) >10 × 10⁹/L
- (C) >20 × 10⁹/L
- (D) >30 × 10⁹/L
💡 Click to Reveal Answer & Nelson Rationale
Option B (>10 × 10⁹/L)
In
children and adolescents with bone marrow failure secondary to chemotherapy,
prophylactic platelet transfusions are recommended to maintain a platelet count
>10 × 10⁹/L when the patient is clinically stable, has no active bleeding,
and has no additional hemorrhagic risk factors. This threshold minimizes the
risk of spontaneous bleeding while avoiding unnecessary platelet transfusions
and their associated complications.
![[fef965f3_image_61b273fb2ebe45fca2d67b96fcb72640.png]]
<b><font color="#54acd2">
A 2-week-old preterm
neonate develops severe thrombocytopenia during an episode of late-onset
sepsis. Bone marrow examination reveals numerous small, cytoplasmically mature
megakaryocytes. The treating physician explains that the neonatal marrow
response to thrombocytopenia differs from that of older children and adults.
Which of the following best describes the characteristic neonatal megakaryocyte
response to increased platelet demand?
---
- (A) Increase in megakaryocyte size and ploidy, followed by an increase in megakaryocyte number
- (B) Increase in megakaryocyte number and ploidy, with minimal change in megakaryocyte size
- (C) Increase in megakaryocyte size and cytoplasmic maturation, with little change in megakaryocyte number
- (D) Increase in megakaryocyte number without a proportional increase in megakaryocyte size or ploidy
💡 Click to Reveal Answer & Nelson Rationale
Option D (Increase in megakaryocyte number without a proportional increase in megakaryocyte size or ploidy)
During
increased platelet demand, older children and adults initially respond
by increasing megakaryocyte size and ploidy, followed over the next 3–5
days by an increase in megakaryocyte number. In contrast, neonates
respond predominantly by increasing megakaryocyte number, while failing
to proportionally increase megakaryocyte size or ploidy. Although
thrombopoietin stimulates cytoplasmic maturation, polyploidization remains
relatively limited and may even be inhibited, resulting in numerous small,
cytoplasmically mature megakaryocytes with reduced platelet-producing
capacity.<o:p></o:p>
**<font color="#54acd2">
</font>**
<b><font color="#54acd2">
A 5-year-old boy with
severe aplastic anemia develops persistent febrile neutropenia despite
appropriate broad-spectrum antibacterial and antifungal therapy. Because of
ongoing life-threatening infection, granulocyte transfusion is planned. Which
of the following is the most appropriate donor selection strategy to minimize
transfusion-related complications?
---
- (A) CMV-seronegative donor with ABO/Rh-compatible granulocyte product
- (B) ABO/Rh-compatible donor with recently documented negative HIV and hepatitis testing
- (C) CMV-seronegative donor irrespective of ABO/Rh compatibility
- (D) Irradiated ABO/Rh-compatible granulocyte product
💡 Click to Reveal Answer & Nelson Rationale
Option A (CMV-seronegative donor with ABO/Rh-compatible granulocyte product)
Granulocyte
transfusions are reserved for selected patients with severe neutropenia and
life-threatening infections unresponsive to antimicrobial therapy. Because
granulocyte concentrates contain a large volume of contaminating red blood
cells, the donor must be ABO/Rh compatible with the recipient to minimize the
risk of hemolytic transfusion reactions. In addition, donors should be CMV-seronegative
to reduce the risk of transfusion-transmitted CMV infection in
immunocompromised recipients. Donors are also selected from experienced
individuals with recently documented negative HIV and hepatitis testing, and
the granulocyte product should be transfused as soon as possible after
collection because granulocyte viability rapidly declines during storage.<o:p></o:p>
**<font color="#54acd2">
</font>**
<b><font color="#54acd2">
A
7-year-old child with disseminated intravascular coagulation requires urgent
plasma transfusion. The blood bank informs you that fresh-frozen plasma (FFP)
is currently unavailable, but plasma frozen within 24 hours of collection (F24)
is immediately available. Which of the following is the most appropriate
management?<o:p
---
## 📖 Reference Citations & Explanations
- (A) Delay plasma transfusion until FFP becomes available because F24 has lower factor VIII levels
- (B) Transfuse F24, as it is clinically interchangeable with FFP for routine pediatric indications
- (C) Transfuse F24, but increase the transfusion volume to compensate for lower factor V and VIII levels
- (D) Use cryoprecipitate instead of F24 because it provides more effective coagulation factor replacement
💡 Click to Reveal Answer & Nelson Rationale
Option B (Transfuse F24, as it is clinically interchangeable with FFP for routine pediatric indications)
Two
plasma products are available for transfusion: fresh-frozen plasma (FFP),
frozen within 8 hours of collection, and F24, frozen within 24 hours. Although F24
contains modestly lower concentrations of factors V and VIII (generally ≤25%
lower), it has
been shown to be equally efficacious for all routine indications requiring
plasma transfusion in infants and children. Therefore, plasma transfusion
should not be delayed when F24 is available. The usual starting dose is 15
mL/kg, with subsequent dosing based on the specific coagulation factor
deficiency and clinical response.<o:p></o:p>
**<font color="#54acd2">
</font>**
<b><font color="#54acd2">